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ABSTRACT
Selenoproteins, such as glutathione peroxidase, have gained interest for their
ability to act as antioxidants, and their potential to act as anti-cancer agents. Synthesizing
and studying selenoproteins can be problematic, however, due to their propensity to
degrade from over-oxidation. The degradation from over-oxidation can be avoided by the
incorporation of the unnatural amino acid, alpha-methylselenocysteine. A synthesis
utilizing methyl malonic esters was used to synthesize protected (R)-alphamethylselenocysteine efficiently (46% over four steps) and in high enantio-purity (88%
enantiomeric excess). Using similar procedures, the (S)-enantiomer was also synthesized
as well as a beta-analogue.
The use of enzymes in a chemical laboratory is beneficial as they provide an
efficient enantioselective method to synthesize chiral materials. Unless known substrates
are used, the stereochemistry of the product cannot be known with certainty. The Mosher
method employs NMR to analyze an MTPA-derivatized version of a chiral compound,
however, use on congested chiral centers is limited. While sitting in the MTPA-plane
differently than the model predicts, the Mosher method can be used to determine
unknown configurations in alpha-methyl amino acids. By synthesizing two MTPA-based
diastereomers from enantio-enriched alpha-methylselenocysteine, the absolute
configuration of the stereocenter at the alpha-carbon was determined to be an (R)stereocenter.
Within the glutathione catalytic cycle, glutathione reduces the oxidized selenium
of glutathione peroxidase to a selenol, allowing the enzyme to function again, however
glutathione is oxidized to glutathione disulfide. Glutathione disulfide, while oxidized,
ii

cannot operate normally and is needed to be reduced. The action of glutathione reductase
reduces glutathione disulfide to two molar equivalents of glutathione. If both cysteines in
glutathione disulfide are alpha-methyl amino acids, glutathione reductase is unable to
perform the reduction. Work has been done to synthesize an asymmetric cystine and
future work will be to elaborate to the asymmetric glutathione disulfide and study its
inhibitory effects on glutathione reductase.
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CHAPTER I – INTRODUCTION

1.1 Anti-oxidation in Biology
Respiration is an important biological process that allows for the conversion of
small organic molecules to cellular energy in the form of ATP. During aerobic respiration
oxygen is used in the electron transport chain to produce copious amounts of ATP, as
well as water and carbon dioxide. During this process side reactions can occur, which can
produce reactive oxygen species (ROS), such as superoxide radicals, hydrogen peroxide,
and hydroxyl radicals. These ROS then proceed to cause oxidative damage to cellular
machinery and DNA and if not suppressed can lead to chronic diseases, such as cancer,
and even death.1-4 To combat the propagation of the oxidative stress caused by ROS,
organisms have developed a series of redox reactions utilizing antioxidant enzymes and
substrates to reduce the level of ROS in the cell.5 Many of the biomolecules are
reversibly oxidized, converting the ROS to more benign materials, and are then
subsequently reduced by a series of steps back to their original active form.
Many of these redox active biomolecules contain either sulfur or selenium in their
active site, and it is these elements that directly interact with the ROS. Selenium is a trace
metal in the Earth’s crust and is an essential micronutrient for humans. With selenium
labelled as a micronutrient, it unfortunately has a narrow range between deficiency and
toxicity which can lead to several health issues, with deficiencies leading to diseases like
Keshan disease3, 6-7 and an excess leading to selenosis.3, 8 It has been found in over 20
mammalian proteins mainly in the form of the amino acid selenocysteine (Sec).9-12 All
the proteins found containing Sec, such as glutathione peroxidase (GPx), have some
1

antioxidant function owing to selenium’s low redox potential of -381 mV at pH 7.013
which are responsible for maintaining the homeostatic redox environment in cells.
Selenoenzymes work to reduce ROS and other forms of oxidative stress but have
the potential to become overwhelmed. Much research has been undertaken to synthesize
organoselenium compounds that have similar redox capabilities as GPx that are able to
function more efficiently.14-17 Synthesized in the 1920’s, ebselen is an organoselenium
compound that has been shown the exhibit GPx-like activities.18-19 While used in clinical
trials for to treat ischemia from cardiovascular occlusions as well as showing potential
anti-cancer capabilities,5, 20 it exhibits low solubility, as well as potential cytotoxicity.21-22
One class of selenium containing antioxidants that has not been studied
extensively are synthetic peptide-based antioxidants which can exhibit water-solubility,
as well as low cytotoxicity, but can be prone to degradation (See Section 1.2).23
GPx is a key selenoenzyme that
reduces hydrogen peroxide. It acts in a
catalytic redox cycle with glutathione
(GSH) and glutathione reductase (GR).
The catalytic cycle first starts with the
selenium in GPx in the form of a selenol
being oxidized by hydrogen peroxide to a
selenenic acid (Figure 1.1).24-25 The
oxidized GPx (GPxOH) then oxidizes
GSH to form a GPxSG complex,
releasing water as a byproduct. The

Figure 1.1 Glutathione Peroxidase Enzyme
Cycle
2

selenium in the GPxSG complex is then reduced back to a selenol by an additional GSH
producing glutathione disulfide (GSSG) and reforming the active GPx. The GSSG is then
reduced by NADPH with GR acting as a catalyst, closing the catalytic cycle.

1.1.1 Sec and Selenium Incorporation into Proteins
Sec is considered by many to be the 21st natural amino acid. It shares many
commonalities with the other 20 amino acids, such as having its own codon, tRNA, and is
installed into peptides co-translationally verses a post-translational modification like
many other unnatural amino acids.12 The process in which it is added to a peptide,
however, is not as trivial as the other 20 amino acids; since the codon for Sec is the stop
codon UGA, it is needed to be retranslated for Sec insertion.26-28
This entire process, as explained by Turanov et al.,29 and depicted in Figure 1.2,
Sec is biosynthesized by its tRNA first being aminoacylated with serine,30 followed by
the hydroxyl on the serine moiety being phosphorylated. Selenophosphate then acts on
this molecule yielding an active Sec tRNA producing diphosphate as a byproduct. This
charged Sec-tRNA can then add Sec to a growing peptide chain.
Even though the biological pathway is known, there is still inherent difficulty
incorporating Sec into proteins due to its codon being the stop codon sequence UGA.
Without any modifications or secondary structure considerations to the RNA, peptide
synthesis would cease at that point without adding in Sec or any additional amino acids
that followed due to the UGA being treated as a stop codon. To overcome this, cells have
installed a selenocysteine insertion sequence (SECIS) element directly downstream of a
UGA sequence.
3

Figure 1.2 Biosynthesis of a Sec Containing Peptide
(Red) An amino acid with the R-group moiety shown. (Orange) Sec-tRNA. (Purple) Ribosome. (Yellow-green) Growing peptide
chain

This SECIS, discovered by Berry et al.,28 forms a stem loop structure at the 3’ end in the
RNA. With SECIS, coupled with SECIS binding protein 2 (SBP-2), selenocysteine
elongation factor (SeEF), Sec-tRNA, and other cellular machinery, Sec is incorporated
into the growing peptide chain as discussed by Krol in his review.6 It is because of these
extra processes needed for Sec incorporation that lower eukaryotes generally lack the
ability to create selenoproteins.

1.1.2 Selenocysteine Versus Cysteine
Selenocysteine and cysteine (Cys) can perform biological redox processes in the
biomolecules they are contained in. While both Sec and Cys have nearly identical redox
chemistries, with a difference in their redox potential of 20-25 mV,1 Sec is the preferred
amino acid in some enzymes over Cys. Biologically, it seems counter-intuitive to have
4

this bias, specifically when specialized cellular machinery is required to add Sec into
biomolecules, and Cys appearing to function identically to Sec. Both amino acids also
have the same oxidation states and readily form dichalcogens when oxidized, which can
then be easily reduced. Their differences become more obvious when the higher
oxidation states are accessed. The work by Hondal et al.31 demonstrated that at the 6+
oxidation state of both sulfur and selenium are deactivated from further redox
chemistries, however their ability to
reach this oxidation state vary
significantly (Figure 1.3). At the 4+
oxidation state, the propensity of
sulfur to be further oxidized to 6+ is
much higher than selenium. As
shown by Hondal et al., it only

Figure 1.3 Redox Cycles of Selenium and Sulfur

takes 2 equivalence of an oxidizer for sulfur to start converting to the 6+ oxidation state,
whereas selenium only starts converting to the 6+ oxidation state after 3 equivalences.31
Once oxidized, it is easier for selenium to be reduced and to proceed with additional
redox reactions. This ability to readily cycle from higher oxidation states to lower and
more active oxidation states may be why Sec is preferred over Cys in certain biological
systems.
Besides redox chemistry, there are other differences between Sec and Cys that
biology can use to its advantage. The pKa of the selenol in Sec is approximately 5.7,32-33
which at physiological pH, the selenium is largely deprotonated. Conversely the pKa of
the thiol on Cys is 8.5 and at physiological pH the sulfur is only partially deprotonated.34
5

Since Sec is mostly deprotonated under these conditions the selenium would be more
nucleophilic and be reactive towards the ROS than Cys. Many selenoproteins have
known Cys homologues in biology, however they typically have several orders of
magnitude lower activities when compared to the normal Sec containing protein.35

1.2 Sec Degradation
Under normal circumstances Sec, can easily reduce ROS to benign compounds,
however there is a threshold at which it can become overwhelmed and become overoxidized to form a seleninic acid. While selenium in this oxidation state can be easily
reduced to lower oxidation states, the amino acid can degrade as this species. A typical
reaction used in organoselenium chemistry is the -elimination of a selenoxide to form an
alkene.36-38 The oxygen on the selenium can deprotonate the -hydrogen of the amino
acid which then eliminates selenium from the amino acid, forming dehydroalanine.23, 39-40

Scheme 1.1 Selenocysteine Degradation

Once dehydroalanine is formed, the biomolecule loses the ability to perform the redox
chemistry that it could with Sec.41 Without the -hydrogen present, -MeSec (methylselenocysteine) cannot degrade by this pathway. With this extra stability -MeSec
should have increased longevity, enabling it to cycle through more redox reactions,
allowing the biomolecules to stay active longer.42
6

1.3 Unnatural Amino Acids
The normal 21 amino acids are readily used to make proteins, each amino acid
with its difference in property, allowing for the many shapes and functions that proteins
have. There, however, are many unnatural variations that the cell itself can create and
utilize, typically formed from post-modifications to peptides.43 These new amino acids
offer new properties, and can possibly change protein folding.44
There are many unnatural amino acids (UAAs) that can be incorporated into a
protein that are not biosynthesized, that scientists use, to purposely manipulate the protein
in specific ways. These UAAs, just like their biosynthetic counterparts, can change the
protein and give more desirable properties. One such class of UAAs is -methyl amino
acids (-MeAAs), which replace the hydrogen on the -carbon with a methyl group. This
methyl group adds steric hindrance that the hydrogen atom would not, which results in
added rigidity of the  and  dihedral angles.45 The values that  and  for -MeAAs
take typically give helical structures or induce -turns. Aib (-methylalanine), the
simplest -MeAA, is a strong helix former, inducing either - or 310-helical structures, as
well as a -turn promoter.
With the inclusion of -MeAAs, the protein is typically more stable. All
proteogenic amino acids, excluding glycine, are L-stereoisomers. Under basic enough
conditions amino acids have the propensity to racemize at the -carbon, which could
cause the protein to misfold and degrade.46-47 Within physiological pH, the rate of
racemization is negligible, but racemization can be a problem when studying and
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synthesizing peptides. Since there is no longer an acidic hydrogen on the -carbon in MeAAs, racemization at this position is prevented, allowing for a more stable protein.
Besides racemization, -MeAAs can also resist enzymatic cleavage. Khosla et
al.48 reported that when angiotensin II is modified to contain -MeTyr (methyltyrosine) at the 4th position in the peptide, the molecule completely resists
digestion by -chymotrypsin, while the natural substrate degraded into two components
from the scission of the N-terminal amide bond to the tyrosine. Based on their findings,
the incorporation of -MeTyr did very little to change the protein conformation and the
protein retained almost all its biological function. Much of the enzymatic degradation
resistance can be argued to be caused from the steric effects of the -methyl group.
In biological systems, besides resisting enzymatic cleavage, -MeAAs can inhibit
enzymatic function. Inhibitors act by binding to the enzyme and preventing it from acting
on its substrate.49 Substrates with -MeAAs may still have the ability to bind its enzyme,
but the change in geometry afforded by the -methyl groups may prevent enzymatic
action. One example in literature is an unnatural form of glutathione disulfide which has
-methyl groups on both cysteines (G’SSG’) as described by Kedrowski et al.50 This
molecule is able to enter the active site of GR, but because of the steric hinderance
imposed by the -methyl groups, G’SSG’ is unable to be acted on. Another example
reported by Nakazawa et al.51 is the action of -methylphenylalanine on aromatic Lamino acid decarboxylase. Without the addition of the cofactor pyridoxal phosphate, the
enzymes function is inhibited.
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1.4 Enzymes in Synthetic Chemistry
Many biological compounds that chemists synthesize contain at least one
stereocenter, and careful consideration of reaction choice is needed to avoid the
formation of epimers. To obtain a desired configuration from a reaction, chemists can
employ several techniques: chiral catalysts, chromatographic resolutions, or enzymes.
The benefit to chiral catalysts is that reactions do not need stoichiometric amounts of the
catalyst, and many reactions can produce high enantioselectivity with very low loading
amounts.52 These catalysts, however, can be cost preventative to use as many of them use
precious metals and expensive ligands to function.53-54
Another method that can be employed is utilizing chromatography for a chiral
resolution of a racemic mixture. This method can allow for efficient separation of two
racemates by using a chromatography column that has been functionalized with a chiral
ligand. It is typically not known which enantiomer is which unless comparisons can be
made with retention times of a known analyte. A benefit to this method, besides chiral
resolution, is that enantiomeric excess (%ee) can be determined from the
chromatographic trace on the HPLC system if an enantioselective reaction was used.
Enzymes are a ubiquitous resource to asymmetric synthetic chemistry. Many
enzymes perform specific reactions have specific substrates that they act on,55-56 however
many enzymes are able to be used for more general reactions. Enzymes are useful
because many of them are inexpensive, compared to chiral catalysts. Even though many
are substrate dependent, enzymes typically offer high stereoselectivity, which can be
altered depending on the specific enzyme and reaction conditions.57-58 One common class
of enzymes used are esterases which can selectively hydrolyze esters to carboxylic
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acids.59-61 A commonly used esterase is pig liver esterase (PLE) as it possesses a wide
substrate scope. With PLE having a broad scope of substrates, its stereoselectivity has the
potential to fluctuate depending on the substrate used. To aid in predicting which
stereoisomer will be produced, Jones et al. created a model of the active site of PLE by
computational methods from experimental data (Figure 1.3).62 The Jones model, while
adequate in initial predictions, cannot be used to accurately determine the stereochemistry
of the hydrolysis product. Crude PLE was used to form the Jones model, however there
are six isoenzymes within the crude enzyme. The isoenzymes can vary drastically from
one another considering yield, enantioselectivity, and stereopreference.57-58 To confirm
absolute configuration and %ee of the enzymatic product, empirical methods, such as
spectroscopy and polarimetry, must be used.

Figure 1.3 Expected Orientation of -MeSer, -MeCys, and -MeSec Malonic Esters in
PLE Using the Jones Model

1.5 Unnatural Amino Acids and Glutathione Reductase
The GSH catalytic cycle is a process that is critical for proper cellular function.
Substituting -MeAAs for key amino acids in peptides can allow for greater stability and
prevent degradation associated with high levels of oxidative stress.42 The incorporation of
10

-MeAAs in this cycle can also change how enzymes interact with their substrates. When
both cysteines are -methylated in glutathione disulfide (G’SSG’), GR cannot reduce the
disulfide bond present and G’SSG’ acts as a competitive inhibitor.50 With the activity of
GR decreased from inhibition, the concentration of ROS will increase as the catalytic
cycle becomes bottle-necked. It is unknown if the inhibition behavior will differ if an
asymmetric glutathione disulfide is used instead, and future work will focus on its
synthesis and function as a substrate for GR.
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CHAPTER II – SYNTHESIS OF -METHYLSELENOCYSTEINE AND ITS
RELEVANT ANALOGUES

2.1 Introduction
Selenium is an essential trace nutrient needed for many higher organisms, which
allows for the biosynthesis of selenocysteine (Sec) and selenoproteins. These
selenoproteins typically have anti-oxidative properties which reduce oxidative stress
within cells. The study and synthesis of selenoproteins is not a trivial endeavor, due to the
potential degradation from -elimination.23 One of the first syntheses of Sec was
performed by Fredga in 1936 by the action of potassium diselenide on 3-chloroalanine
methyl ester.63 Other routes have been used to synthesize Sec analogues, with a popular
method being selenylating an activated serine with a nucleophilic selenium species,33, 39,
64-65

which mirrors Fredga’s method for selenylation. Another method first performed by

Shirahama et al., and utilized by many chemists after, is the nucleophilic ring opening of
a -lactone by a selenylating agent.66

Scheme 2.1 General Methods Previously Used to Synthesize Sec
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Both methods allow for high yielding reactions and enantiopure products if enantiopure
materials are used. Finally, Reich et al. pioneered a synthesis from a glycine analogue
forming a racemic Sec analogue from enolate chemistry,67 using similar reagents to what
the Masterson lab developed (Scheme 2.2).

Scheme 2.2 Masterson Lab Enolate Synthesis

A few select -MeSec analogues have been synthesized in the Masterson lab. All
of them boast robust chemistries that can produce the target molecules in minimal steps,
which will be discussed in this chapter: selenylation, desymmetrization, amine formation,
and ester hydrolysis (Scheme 2.3).

Scheme 2.3 Synthetic Strategy to Synthesize -MeSec Utilizing Enolate Chemistry
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2.2 Selenylation
2.2.1 Strategies in Literature
Chemists rely either on selenium’s electrophilicity or nucleophilicity to selenylate
molecules. Selenylation of an organic compound, depending on the necessary conditions
and reagents used, can be a straightforward reaction, or quite complex. Once incorporated
into the substrate, care is needed to avoid oxidation of the selenium, especially if there is
a -hydrogen to the selenium. With a -hydrogen present, selenium can eliminate from
the compound, leaving an alkene (see Scheme 1.1 on page 6). Common oxidizers used
for this process are peroxides, but other oxidants can be employed.38
Electrophilic selenylation occurs using a selenyl halide. The use of these types of
species is in a selenoxide elimination reaction to from -unsaturated ketones from
enolates and proceeds through a syn-elimination process (Scheme 2.4).68-69 Usually
hydrogen peroxide is used as an oxidant in these reactions, however this leaves the
ketone susceptible to a Baeyer-Villiger reaction, forming an unwanted ester. To avoid
this problem, sodium periodate or ozone can be used.38

Scheme 2.4 Selenoxide Elimination

Another reaction that utilizes electrophilic selenium to selenylate a substrate is the
oxidation of alkenes to form vinyl alcohols by utilizing selenium dioxide. Sharpless et al.
explored this reaction mechanism (Scheme 2.5) and determined it to occur by the action
14

of the alkene attacking the selenium of selenous acid and the simultaneous deprotonation
of the vinylogous proton by selenous acid, followed by a loss of water from the selenous
acid moiety. Once at the seleninic acid intermediate, a [2,3]-sigmatropic rearrangement
occurs, followed by solvolysis to produce the vinyl alcohol.70-72

Scheme 2.5 Selenium Dioxide Oxidation

While electrophilic selenylation is an option to selenylate substrates, nucleophilic
selenylation can also be used. Many of these reactions take advantage of selenium’s high
nucleophilicity, especially when in the selenolate form. Selenolates can attack
electrophilic carbons, such as alkyl halides, to form a carbon selenium bond. Selenylation
with these species acts through an SN2 mechanism, and a sterically hindered carbon
center will stifle the reaction.
Formation of nucleophilic selenium species has been previously done by the
reduction of elemental selenium with alkali metals, such as sodium or potassium, creating
a reactive metal selenide or diselenide depending on the stoichiometry used.73 These
reactive species can then be used to ultimately form selenides, diselenides, and
polyselenides. Similar results can be achieved when using hydride sources, such as
sodium borohydride, when forming a selenylating species from elemental selenium.33, 7476

Selenylating species can also be formed by reduction of diselenides using hydride

sources, which will mostly result in selenide products being formed.73
15

More specialized reagents can also be used to selenylate substrates. One such
compound is Woolins’ reagent, which is the selenium equivalent to Lawesson’s
reagent.77 This reagent exist as a dimer, but its active phenyldiselenophosphine
intermediate can be readily created in situ by reflux (Scheme 2.6). The reactive
intermediate of Woolins’ reagent especially resembles selenophosphate, which is what
the cells use to selenylate the phosphorylated serine (See Figure 1.2 on page 4).

Scheme 2.6 Woolins’ Reagent and Its Action on -MeSer

Lawesson’s and Woolins’ reagents are routinely used to convert carbonyl containing
functional groups to their higher chalcogen counterparts, however work has been done by
Iwaoka et al.78-79 that show that Lawesson’s and Woolins’ reagents can convert serine
and -methylserine (-MeSer) to the Cys and Sec analogues, respectively (Scheme 2.6).
There are problems with these conversions which include low to moderate yields as well
as potential loss of optical purity.

2.2.2 -Methylserine to -Methylselenocysteine Hypothesis
It was hypothesized that synthesizing -MeSec could be accomplished through a
conversion from -MeSer. Considering what substrates were on hand, it was decided to
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explore the possibility to selenylate -MeSer as a method of obtaining -MeSec. It was
hypothesized that because of selenium’s superior nucleophilicity, selenylation should be
possible on the hindered neopentyl-like methylene carbon, especially if the hydroxide
group was activated by converting it to a sulfonic ester (Scheme 2.7).

Scheme 2.7 Selenylation Strategy of an Activated -MeSer

Scheme 2.8 Synthesis of the Substrate to Selenylate

The half-ester benzyl protected analogue 1 (70% ee) of -MeSer was the starting material
used in these attempts and needed to be converted to a substrate for selenylation (Scheme
2.8). The carboxylic acid of 1 was converted to a Boc protected amine 2 by using a
Curtius rearrangement to form an isocyanate intermediate, which was then immediately
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transformed to a carbamate by an alcohol addition with tert-butyl alcohol. The benzyl
protected alcohol was then deprotected by hydrogenation with hydrogen gas and
palladium in ethanol to afford 3 in high yields. The free alcohol was then converted to a
sulfonic ester in the presence pyridine and the sulfonyl chloride to produce 4a and 4b.
With 4a and 4b in hand, different selenylating agents could then be used to
attempt selenylation. The first one attempted, 4-methoxybenzyl diselenide 5, was not
commercially available and had to be synthesized. Elemental selenium was reduced with
lithium triethylborohydride (LiBEt3H) and then reacted with 4-methoxybenzyl chloride
(MobCl) to produce 5 in low yields (Scheme 2.9).

Scheme 2.9 Synthesis of Non-commercial Selenylating Reagents

A selenylation of 4a was attempted using 5, but 5 failed to reduce with sodium
borohydride based on 77Se NMR. Another selenylating agent was then tested, the selenide
anion, Se2-. The selenide anion was created in situ using LiEt3BH, and then was used to
selenylate 4 (Scheme 2.10), however only 4a converted from starting material.
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Scheme 2.10 Initial Selenylation Attempt

This, unfortunately, created a mixture of selenide 7 and diselenide 8, which having very
similar polarities, were unable to be separated by chromatography. Utilizing the chemical
differences between a selenide and diselenide, it was possible to reduce 7, and create an
asymmetric selenide by trapping the formed selenolate with an alkyl halide. This was
done by reducing 7 using NaBH4 and then selenylating MobCl creating 9. With a large
difference in polarity, 9 was easily able to be isolated from 7, but only a minute amount
of 9 was able to be isolated.
With the poor yield from the previous selenylation attempts, other selenylating
agents were considered, one being potassium selenocyanate (KSeCN). This was an
attractive selenylating reagent because it should act as a non-bulky nucleophile and after
the initial selenylation, the cyanate could be removed by hydrolysis, resulting in a
diselenide.73 While in principle the reaction should work, it failed to convert the substrate
to a selenylated product.
A final selenating reagent considered was tert-butyl diselenide 6. This reagent
was chosen because of the previous experience using the sulfur variant used in the
synthesis of -MeCys. This was synthesized by first reacting tert-butyl magnesium
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chloride with elemental selenium (Scheme 2.9). Selenium can insert itself between the
carbon-magnesium bond, and with quenching, will form a selenol, which can then be
easily oxidized to 6. A selenylation was attempted with a reduced 6, however the reaction
failed to produce product.
With nucleophilic selenylation acting as a SN2 mechanism there is a reasonable
explanation as to why there was a low success rate with selenylation using 4 as a
substrate; the selenylation site is on a neopentyl-like carbon. Normally, only the
congestion of the electrophilic site is considered in the SN2 mechanism, however, if the
neighboring group is sterically hindered it can prevent the nucleophile from accessing the
electrophilic center to the point which can be analogous to attempting a substitution on a
tertiary carbon.80-81

2.2.3 Synthesis of -MeSec Using Malonate Chemistry
With the low success of selenylation at the desired neopentyl-like carbon, another
strategy the synthesis of -MeSec is needed to be explored. In the Masterson group,
several UAAs have been synthesized from a common starting material, methyl malonic
esters. The functional groups of the UAAs can be added to the malonate backbone
utilizing enolate chemistry. Further functionalization of the malonate allows for
transformation to an amino acid which will be discussed in later sections. While this is a
robust synthetic strategy, as proven with past syntheses, a stable selenium containing
alkylating agent was needed to successfully alkylate the malonic ester using enolate
chemistry (Scheme 2.11). The appropriate alkylating agent can be made from 6, by
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reduction and then chloroalkylation with DCM to incorporate the needed -CH2X
fragment.

Scheme 2.11 Seleno-Alkylation Utilizing the Enolate Strategy

Before the alkylating agent could be made, an appropriate reducing agent needed to be
found, due to the failure of the diselenide reductions in the earlier selenylation reactions.
This was investigated utilizing 77Se NMR before and after the addition of a reducing
agent, which will show a large chemical shift for selenium if reduction took place. From
these studies it was found that of the available reducing agents, LiEt3BH and sodium
bis(2-methoxyethoxy)aluminum hydride (Red-Al) were the only reducing agent that were
able to reduce 6 (Table 2.1). To confirm whether this selenylating reagent could
overcome the steric effects of the neopentyl-like position, 4b was added to the reduced
form of 6, unfortunately no selenylated product formed.
With a proper reducing agent discovered, the seleno-alkylating agent 10 could be
made. This was done by reducing 6 in THF with LiEt3BH, and then cannulating the
formed selenolate to a round bottom containing DCM, which formed 10 (Scheme 2.12).
Analysis by NMR revealed that 10 had a distinct shift difference from 6, 488 ppm to 519
ppm, which was to be expected since selenium is quite sensitive to the electronic
environment.82 Upon sitting at room temperature for an extended length of time, 10 did
seem to degrade to the dimer 11, so creating it in situ was executed.
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Table 2.1 Reduction Studies of 6a

[H]
Blank
NaBH4
Blank
LiEt3BH
Blank
H3PO2

d-solvent
Ethanol-d6
Ethanol-d6
THF-d8
THF-d8
EtOH-(D2O)b
EtOH-(D2O)b

77

Se ppm
486.5
486.3
487.6
164.5
486.1
484.5

mol 6
198
121

247

mol [H]
0
1450
0
200
0
1550

H3PO2

EtOH-(D2O)b

484.2

PPh3

EtOH-(D2O)b

484.3

394

1020

LiEt3BH

THF-(D2O)b

490.1c

228

500

Red-Ald

THF-(D2O)b

520.2e

313

900

Notes
White solid formed
Turned red
Without heating
With heating, turned
turbid
White solid formed
4b was added after
reduction
Color changed from
yellow to colorless

a) All reactions were performed in an NMR tube. b) D2O was added as an external standard for non-deuterated solvents. c) 77Se NMR
data was obtained after workup d) Red-Al is sodium bis(2-methoxyethoxy)aluminum hydride e) DCM was used in the reaction to
trap the selenolate through a chloroalkylation and the observed chemical shift is a result of that product

After the formation of 10, the solvent was removed by vacuum and the resulting oil was
then cannulated into a flask containing an enolate formed from the deprotonation of
diethyl methylmalonate with sodium hydride. Based on NMR and mass spectrometry
(MS), this method was successful in adding selenium to the desired substrate creating 12
with low yields (Scheme 2.12) which experienced a large chemical shift in 77Se NMR.
Besides creating 12, a byproduct 11 was also formed, which seemed be an issue with the
synthesis of 10 or a degradation product in the formation of 12. With these low yields, the
reactions can be later optimized.
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Scheme 2.12 Synthesis of 11 and Its Use in Alkylating Diethyl Methylmalonate and 77Se
NMR of the Reactions
77

Se NMRs of 6 and 12 were after purification.

2.2.3.2 Optimizations to Selenylation
With the successful, but low yields in the overall selenylation process,
optimizations could be made. There were many places where optimizations could be
made, from the synthesis of the diselenide, seleno-alkylating agent, as well as the
alkylation itself. Synthesizing the diselenide was able to be accomplished with much
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higher yields. Initially, once the selenium inserted into the carbon-magnesium bond, the
reaction was quenched with ammonium chloride, however this sometimes caused the
reaction to form a slurry, which was found to lower the yields.

Table 2.2 Diselenide Synthesis

Trial
1b
2b
3
4
5
6
7
8
9
10
11
12
13
14
15
16

H+
[O]
Yield of 6 (%)
c
NH4Cl
Air
16
NH4Cl
Airc
12
NH4Cl
Air
49
NH4Cl
Air
18
NH4Cl
Air
39
NH4Cl
Air
13
NH4Cl
Air
35
HCl
Air
57
HCl
Air
66
HCl
Air
62
HCl
Air
54
HCl
Air
53
c
HCl
Air
21
HCl
O2
27
HCl
Br2
30
HCl NaH2BO4c,d
82e

a) Grignard reagent was always in excess of selenium. b) Grignard was synthesized for the reaction instead of being purchased. c)
Oxidation time was 3 hours or less. d) Oxidized from the selenolate instead of the selenol. e) Similar yields obtained by other lab
members using this method.

It was later found that quenching with concentrated HCl was much more effective. Based
on the work done by Mckillop et al.,83 the rate of oxidation of the selenol is much slower
than the rate of the selenolate. When previously oxidizing from the selenol, oxidation was
found to be incomplete because some unoxidized selenol was removed by vacuum
distillation lowering the yields of 6. The highest yields (trial 16 Table 2.2) were obtained
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by washing the selenol with base to deprotonate it to form a selenolate which partitioned
to the aqueous phase. The oxidation was accomplished in a water/hexanes biphasic
mixture, so once the selenolate was oxidized, it would partition from the aqueous phase
to the organic phase, allowing for a much more facile isolation. As suggested by
Mckillop et al., sodium perborate was used as the oxidizing agent instead of air since it
was a reliable, consistent, and robust oxidant for selenium species. Using this method
allowed for yields to improve to 82% after vacuum distillation.
Another potential for low yields within the alkylation process was the presence of
boron compounds from the diselenide reduction interfering with the reaction. Using 11B
NMR, it was found that boron complexes existed in the reaction mixture from the
synthesis of 10, with these complexes persisting through different purification techniques
(Scheme 2.13). Several alternative methods that avoided the use of boron-based reducing
agents for the synthesis of 10 were attempted, but the best was the aluminum based
reducing agent, Red-Al (Scheme 2.14).
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Scheme 2.13 11B NMR Analysis of 10 Attempting to Remove the Boron Species Through
Different Workup Methods

Scheme 2.14 Attempts to Synthesize 10 Without a Boron Based Reducing Agent

It was discovered that after the synthesis of 10, with the aluminum byproducts were
easily removed by a solution of sodium potassium tartrate. Previously the reduction was
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performed in a separate flask and then the selenolate was cannulated into a flask
containing DCM, but it was discovered that performing the reduction in DCM by adding
Red-Al dropwise, was a very efficient process to cleanly produce 10. This new reducing
agent and method of synthesizing 10 directly increased the yield of the selenylation
reaction from 26% to 80%.

2.3 Introduction of Chirality
With the successful synthesis of 12, chirality needed to be introduced. Since 12 is
a symmetrical molecule, a controlled desymmetrization is needed, specifically an
enantioselective hydrolysis of one of the two esters. Enantioselective hydrolyses are
carried out in the Masterson lab by employing enzymes, usually pig liver esterase (PLE).
Previously it was discovered that PLE had great enantioselectivity with the -MeCys
malonic ester analogue, so it stood to reason that the -MeSec variant should as well,
since the only difference between the two is a single atom. Using phosphate buffer at pH
7.4, a biphasic mixture with 12 was made and PLE was added. The pH of this reaction
was kept constant by the addition of NaOH and after the reaction the half-ester enzymatic
hydrolysis product 13a was isolated (Scheme 2.15). A racemic half-ester 13b was also
prepared by utilizing LiOH in a hydrolysis. With both compounds in hand, NMR samples
were made that was spiked with an equimolar amount of (S)--methylbenzylamine to
determine percent enantiomeric excess (%ee), however, neither the methylene protons or
the ethyl ester protons were able to be resolved in the diastereomeric salts to give
accurate results (Scheme 2.16).
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Scheme 2.15 Enzymatic and Racemic Hydrolyses of Selenylated Malonate

Scheme 2.16 1H NMR Spectra of the Downfield Aliphatic Signals to Determine %ee
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Scheme 2.17 Synthesis of 15a and 15b from Dimethyl Methylmalonate

Scheme 2.18 The Synthesis of 14 and 15 and the %EE Determination by 1H NMR
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From these results, it was decided that performing the hydrolyses on the methyl
diester could potentially allow for better resolution. A seleno-alkylation was implemented
on dimethyl methylmalonate producing the selenylated diester 14. Using identical
procedures, enzymatic and racemic hydrolyses were carried out on 14 to produce the
half-esters 15a and 15b (Scheme 2.17). Using (S)--methylbenzylamine in equimolar
amounts to create the diastereomeric salts, NMR samples were made and analyzed by 1H
NMR. The peaks from the methyl ester proton signals were not resolved enough to use
their integrations, but the methylene proton signals were, and it was determined that the
PLE hydrolysis gave 88% ee (Scheme 2.18).
With the enantiomeric excess ascertained, the absolute configuration around the
-carbon was unknown. Based on comparisons to the 1H NMR spectra of 15 (Scheme
2.14) with the spectra sulfur analogue of known configuration84 the methoxy proton
signals for both molecules share the same enantiomeric intensity patterns. The optical
rotation of 15a also shares the same direction of rotation with its sulfur analogue (-2.1° at
c = 1.07 and -1.0° at c = 1.00 respectively), which suggests the absolute configuration of
15a is (R) matching the sulfur analogue. This hypothesis was also supported by past
literature which states that PLE does prefer to create the (R)-enantiomer from a diester.6062, 84

The determination of the absolute stereochemistry of the -carbon will be discussed

in Chapter III.
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2.4 Curtius Rearrangement to Introduce Amine Functionality and Acid Hydrolysis
of the Methyl Ester
Now that chirality has been introduced, amine functionality needs to be
incorporated. With a carboxylic acid present, it can be easily converted to an acyl azide,
and then, through a thermally induced Curtius Rearrangement an isocyanate can be
formed. Once the isocyanate is formed, an alcohol can be added to create a carbamate.
Depending on the alcohol added, the desired carbamate can be formed to allow for
orthogonal deprotections; if tert-butyl alcohol is used, a Boc group is created, which is
resistant to basic conditions, or if 9-fluorenylmethanol (FmocOH) is used, an Fmoc group
is created, which is resistant to acidic conditions. To increase the reactivity of the alcohol
towards the isocyanate, a Lewis acid is needed to facilitate the reaction, and titanium
reagents normally are used, such as titanium isopropoxide (Ti(OiPr)4).
Creating the acyl azide and performing the Curtius Rearrangement efficiently
converted to the isocyanate based on IR spectroscopy by monitoring the isocyanate
stretch formation at 2252 cm-1, however the alcohol addition was low yielding on the
Fmoc product 16 (Scheme 2.19). Analysis with 1H NMR revealed that the isopropoxide
moiety from Ti(OiPr)4 was adding to the isocyanate instead of FmocOH, which created
an isopropyl carbamate 17 instead of the desired Fmoc carbamate. To avoid this side
reaction, hydrolyzing the isocyanate with sodium bicarbonate to an amine 18 was
attempted, however based on MS, this led to multiple chain lengths of oligopeptides (19)
to form. Another titanium-based Lewis acid was considered, titanium tert-butoxide
(Ti(OtBu)4). Literature suggested that Ti(OtBu)4 is more resistant to hydrolysis than
Ti(OiPr)4, and if hydrolysis does occur, tert-butoxide will be non-nucleophilic.85
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Scheme 2.19 The Transformation of the Half-Ester 15a to an Fmoc Protected Amine
Yields of the unwanted products, 17 and 19, were not calculated.

Another benefit to using Ti(OtBu)4 is that it possesses dual Lewis acid – Lewis base
character, which aids in the reaction. The titanium portion of the molecule would have
acidic character, being attacked by the isocyanate oxygen, and in turn, activating the
isocyanate carbon, and the tert-butoxide would have basic character deprotonating the
oxonium cation from the alcohol addition. Using this new Lewis acid did allow for a
cleaner reaction, which produced moderate yields of 16.
With the successful Fmoc protection complete, the final step in the synthesis is to
perform a hydrolysis on the methyl ester. The hydrolysis needs to be completed in acidic
conditions due to Fmoc being base-labile. Using freshly made 5 M HCl in dioxane, the
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methyl ester on 16 was successfully hydrolyzed forming a carboxylic acid 20 in high
yields. The acid catalyzed ring opening of dioxane to form low molecular weight
poly(ethylene glycol) was seen, but this byproduct was easily removed by aqueous
washes.

2.5 Incorporation into Peptides
Once 20 was synthesized two peptides were synthesized in the Hondal lab with
the sequence of H-XXX-Gly-Thr-Thr-Val-Arg-Asp-Tyr-Thr-Gln-OH. At the XXX
position one peptide contained natural Sec, and the other contained -MeSec created
from 20. This sequence was chosen because it corresponds to a sequence in the active site
of GPx.12 The anti-oxidative capabilities of these peptides were measured through a
coupled glutathione reductase assay (Scheme 2.20) using the methods developed by
Wilson et al.15

Scheme 2.20 Coupled Glutathione Reductase Assay

Without any hydrogen peroxide, both peptides had near zero activity, and once hydrogen
peroxide was added the peptide containing -MeSec did have a slight kinetic advantage
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over the native peptide (Figure 2.1). The significant difference between the two peptides
is seen in their stability. Their stability was tested by incubating each peptide in
oxygenated buffer and measuring their normalized activity. It was discovered that after
96 hours, the peptide containing Sec lost 93% of its activity, while the peptide containing
-MeSec only lost 35% of its activity. Additionally, there was visible red precipitate in
the sample of the Sec peptide from deselenylation of the over-oxidized peptide.

Figure 2.1 Enzymatic Activity and Stability Assays of the Seleno-Peptides
Obtained from Wehrle, R. J.; Ste Marie, E. J.; Hondal, R. J.; Masterson, D. S., Synthesis of alpha-methyl selenocysteine and its
utilization as a glutathione peroxidase mimic. J. Pept. Sci. 2019, e3173

2.6 Other -MeSec Analogues Synthesized
With the synthesis of (R)-Fmoc--MeSec(tBu)-OH (20), syntheses of other
analogues were attempted. One very important compound that was synthesized was the
(S)-enantiomer of 20. With both enantiomers of -MeCys occurring naturally in several
biomolecules,84 studying how the opposite enantiomer of -MeSec behaves in biological
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systems is a topic of interest. The synthesis for this molecule essentially followed the
same procedure, except of an extra esterification and a hydrolysis step after the enzymatic
hydrolysis, as well as a variation of the acid hydrolysis at the end of the synthesis to
afford the opposite enantiomer 24 (Scheme 2.21).
From a similar synthetic pathway to the -methyl amino acids, a 2,2-amino acid
analogue was also able to be synthesized (Scheme 2.22). These molecules are important
to synthesize because the quaternary -carbon can cause problems with peptide coupling
from steric hindrance. The methylene group adds distance from the steric congestion of
the -carbon which aids in peptide coupling. Starting from 15a, an Arndt-Eistert
Homologation, which contained a photolytic Wolff Rearrangement, was used to add a
methylene group between the -carbon and the carboxylic acid to form 26.

Scheme 2.21 Synthesis of the (S)-Enantiomer from the PLE product
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Scheme 2.22 -Amino Acid Syntheses

The acid-base workup of 26 produced a large amount of red precipitate, which suggests
that elemental selenium is being liberated from the substrate from a degradation pathway
as eliminated selenium does take on the appearance of a fine red precipitate. Allowing 26
sit for extended periods of time also formed red precipitate, which suggests that this
degradation could be from oxidation and elimination of selenium. Recent literature86 has
found through calculations that malonic acid has the ability to self-catalyze
tautomerization through dimerization. While 26 and 30 are not malonates,
tautomerization is hypothetically possible forming a vinyl diol. If this vinyl diol can
form, then a reaction akin to selenoxide elimination to form an ,-unsaturated carbonyl
can form, eliminating the selenium from the molecule, forming a fumaric acid-like
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structure (Scheme 2.23). The eliminated organo-selenoxide can further degrade back to
elemental selenium. This pathway could explain why 26 and 30 if left standing, does
form a red precipitate.

Scheme 2.23 Hypothesized Degradation Pathway for -Amino Acids

From this point, the remaining 26 was converted to an acyl azide, and with a
Curtius Rearrangement and an alcohol addition, an Fmoc protected amine 27 was
synthesized in low yield. Once as the carbamate, the degradation seemed to not be as
prevalent as the carboxylic acid once 27 was formed. The methyl ester was then
hydrolyzed with 5M HCl in dioxane to form the carboxylic acid 28.
Work towards the enantiomer of 28 was also done. Starting from 22, the
carboxylic acid was converted to a diazoketone, followed by a Wolff Rearrangement to
form 30, however upon sitting red precipitate formed just as what happened with 26.
From this degradation process, not enough material was able to be isolated.
An efficient route to synthesize an enantio-enriched sample of -MeSec has been
completed. This pathway has also been utilized to synthesis of the enantiomer of MeSec as well. The (R)-enantiomer was successfully integrated into a peptide and has
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shown improved performance when compared to the native peptide. The (S)-2,2-amino
acid was successfully synthesized but was found to have problems with degradation
during key steps of the synthesis.

2.7 Experimental
2.7.1 Materials
Solvents for synthesis including N,N-dimethylformamide (DMF) and
dichloromethane (DCM) were purchased from Fisher Scientific (Fair lawn, NJ) or Acros
Organics (Morris Plains, New Jersey). Diphenylphosphoryl azide (DPPA) was purchased
from TCI America (Portland, OR). 9-fluorenemethanol was purchased from Chempep
Inc. (Miami, Fl). Titanium (IV) tert-butoxide was purchased from EMD Millipore. Silica
gel (230-400 mesh) for purifications was purchased from Silicycle (Quebec City, QC,
Canada). Deuterated solvents were purchased from Cambridge Isotope Laboratories
(Andover, MA). All other chemicals were purchased from Sigma-Aldrich (Milwaukee,
WI), Fisher Scientific (Waltham, MA), or ACROS Organics (Pittsburgh, PA).
Hydrogenations were performed using a motorized Parr apparatus. High resolution mass
spectral data on all synthesized compounds were obtained from positive electrospray
ionization on a Bruker 12 Tesla APEX -Qe FTICR-MS with an Apollo II ion source (Old
Dominion, Norfolk, VA) and were either analyzed as solutions in tetrahydrofuran (THF)
or THF/Methanol. NMR spectra were acquired by a 400 MHz Bruker spectrometer. 1H
and 13C chemical shifts () were reported as downfield from tetramethylsilane. Both 13C
and 77Se NMR spectra were 1H decoupled. IR spectra were obtained from a Nicolet
Nexus 470 FT-IR spectrometer with a Smart Orbit Thermo™ diamond plate ATR
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attachment and samples were acquired as a solution from CDCl3 or as neat samples.
Optical rotation data were acquired by a Rudolph Research Analytical Autopol IV
Automatic Polarimeter at 589 nm with a 100 mm quartz cell at ambient temperature.

2.7.2 Synthesis of (S)-N-Boc--MeSer(Bn)-OEt (2)

A 250 mL round bottom flask fitted with a reflux condenser was charged with a
stir bar, 1 (4.19 g 15.7 mmol), toluene (50 mL), and triethylamine (TEA) (2.45 mL, 17.6
mmol). The reaction mixture was stirred for 5 minutes then diphenylphophoryl azide
(DPPA) (3.60 mL, 16.7 mmol) was added and the solution was stirred at room
temperature for 30 minutes and was then heated to reflux for 16 hours. The solution was
then cooled to room temperature and tert-butanol (7.61 mL, 79.6 mmol) and copper (I)
chloride (54.7 mg, 0.550 mmol) were added. The solvent was then heated to reflux for an
additional 24 hours. After cooling to room temperature, the reaction was diluted with
saturated NaHCO3 (100 mL). The mixture was then extracted with diethyl ether (3 × 50
mL). The organic phases were pooled, dried over MgSO4, filtered, and concentrated in
vacuo. The crude oil was purified by gradient flash chromatography and eluted with
hexanes/ethyl acetate (2:1 to 1:1). The product rich fractions (Rf = 0.60 1:1 hexanes/ethyl
acetate) were pooled and concentrated in vacuo to afford 2.57 g (7.62 mmol, 48%) of a
yellow oil. 1H NMR (400 MHz, CDCl3)  5.34 (br s, 1H), 4.56 (d, 2JH-H = 12.3 Hz, 1H),
4.50 (d, 2JH-H = 12.3 Hz, 1H), 4.20 (q, 3JH-H = 7.1 Hz, 2H), 3.76 (br d, 2JH-H = 9.0 Hz,
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1H), 3.70 (br d, 2JH-H = 9.0 Hz, 1H), 1.52 (s, 3H), 1.44 (s, 9H), 1.25 (t, 3JH-H = 7.1 Hz,
3H).
2.7.3 Synthesis of (S)-N-Boc--MeSer-OEt (3)

A 500 mL pressure tube was charged with 2 (2.06 g, 6.12 mmol), ethanol (50 mL)
and 10% Pd/C (212 mg, 0.200 mmol) as a suspension in ethanol (20 mL). The
atmosphere was exchanged for hydrogen and the reaction was agitated for 24 hours under
25 psi of H2 at room temperature. The pressure was released, and the solution was filtered
through Celite. The solvent was removed in vacuo affording 1.49 g (6.03 mmol, 98%) of
a light-yellow oil. 1H NMR (400 MHz, CDCl3)  7.30 (m, 5H), 5.46 (br s, 1H), 4.22 (m,
2H), 3.99 (br d, 2JH-H = 11.0 Hz, 1H), 3.77 (br d, 2JH-H = 11.0 Hz, 1H), 1.47 (s, 3H), 1.44
(s, 9H), 1.29 (t, 3JH-H = 7.0 Hz, 3H).
2.7.4 Synthesis of (S)-N-Boc--MeSer(OTs)-OEt (4a)

A 10 mL round bottom flask was charged with a stir bar, 3 (212 mg, 0.856 mmol),
dichloromethane (DCM) (2 mL), and TEA (240 L, 1.7 mmol). After cooling in an ice
bath tosyl chloride (249 mg, 1.53 mmol) was added and the reaction was slowly warmed
to room temperature. After stirring for 24 hours the solvent was removed in vacuo
leaving a red oily solid. The crude solid was purified by gradient flash chromatography
40

and eluted with hexanes/ethyl acetate (4:1 to 1:1). The product rich fractions (Rf = 0.43 in
1:1 hexanes/ethyl acetate) were pooled and concentrated in vacuo to afford 226 mg
(0.563 mmol, 66%) of a colorless solid. IR (CDCl3, cm−1) 3390, 2979, 2933, 1709, 1598;
1

H NMR (400 MHz, CDCl3)  7.77 (d, 3JH-H = 8.0 Hz, 2H), 7.33 (d, 3JH-H = 8.0 Hz, 2H),

5.23 (br s, 1H), 4.42 (br d, 2JH-H = 9.3 Hz, 1H), 4.38 (d, 2JH-H = 9.5 Hz, 1H), 4.19 (m,
2H), 2.43 (s, 3H), 1.47 (s, 3H), 1.38 (s, 9H), 1.25 (t, 3JH-H = 7.4 Hz, 3H); 13C NMR (100
MHz, CDCl3)  171.4, 154.0, 144.9, 132.7, 129.9, 128.0, 80.2, 70.4, 62.1, 58.5, 28.2,
21.6, 20.6, 14.0; LRMS (ESI+) Calcd for C18H27NO7S [M + Na]+ 424.14 found 424.18.
2.7.5 Synthesis of (S)-N-Boc--MeSer(OMs)-OEt (4b)

A 25 mL round bottom flask was charged with a stir bar, 3 (97 mg, 0.390 mmol),
DCM (1.5 mL), and TEA (110 L, 0.780 mmol). Once cooled in an ice bath, mesyl
chloride (45 L, 0.590 mmol) was added and the reaction was slowly warmed to room
temperature. After stirring for 24 hours the solvent was removed in vacuo leaving a solid.
The crude solid was dissolved in DCM (1 mL) and washed with water (1 mL), saturated
NaHCO3 (1 mL), and water (1 mL). The organic phase was filtered through a MgSO4
plug and concentrated in vacuo to afford 89 mg (0.274 mmol, 70 %) of a colorless solid.
IR (CDCl3, cm−1) 3378, 2974, 2939, 1704; 1H NMR (400 MHz, CDCl3)  5.37 (br s, 1H),
4.71 (br d, 2JH-H = 9.5 Hz, 1H), 4.59 (d, 2JH-H = 10.0 Hz, 1H), 4.26 (m, 2H), 3.01 (s, 3H),
1.53 (s, 3H), 1.44 (s, 9H), 1.30 (t, 3JH-H = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
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171.4, 154.2, 80.3, 70.3, 62.3, 58.6, 37.0, 28.2, 20.6, 14.0; LRMS (ESI+) Calcd for
C12H23NO7S [M + Na]+ 348.11 found 348.19.
2.7.6 Synthesis of 4-Methoxybenzyl Diselenide (5)

A 10 mL, dried round bottom flask fitted with a reflux condenser and a nitrogen
atmosphere was charged with a stir bar, selenium (233 mg, 2.95 mmol) and
tetrahydrofuran (THF) (1.5 mL). This suspension was stirred and LiEt3BH (3.0 mL, 3.0
mmol) was added and the solution was heated to solvent reflux for 1 hour. In another dry,
25 mL round bottom flask was added 4-methoxybenzyl chloride in THF (1.5 mL). Both
flasks were cooled to -78 °C and the contents of the first flask were cannulated to the
second flask. The reaction was slowly warmed to room temperature and stirred for 16
hours. The reaction was then filtered, and the filtrate was concentrated in vacuo. The
crude oil was purified by recrystallization from ethanol to afford 247 mg (0.617 mmol,
21%) of a yellow solid. 1H NMR (400 MHz, CDCl3)  7.16 (d, 3JH-H = 8.6 Hz, 2H), 6.83
(d, 3JH-H = 8.7 Hz, 2H), 3.84 (s, 2H, Se satellites 2JSe‐H = 7.2 Hz), 3.79 (s, 3H).
2.7.7 Synthesis of tert-butyl Diselenide (6)

A flame dried 250 mL round bottom flask was charged with a stir bar, THF (100
mL), and tert-butylmagnesium chloride (48.0 mL, 96.0 mmol). The solution was chilled
in an ice bath and to it was added selenium (5.77g, 73.1 mmol) in several small portions.
The reaction mixture was stirred at room temperature for 30 minutes and was then
quenched with concentrated HCl (8.0 mL, 97 mmol). The reaction mixture was diluted
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with diethyl ether (100 mL) and washed with water (100 mL). The organic phase was
extracted with 1M NaOH (3 × 100 mL). The aqueous phases were pooled and NaH2BO4
(9.0 g, 90 mmol) was added which slowly produced effervescence. To this solution was
added hexanes (30 mL) and this mixture was stirred until effervescence ceased. The
organic phase was decanted, and the aqueous phase was extracted with hexanes (3 × 30
mL). The resulting organic phases were pooled, dried over MgSO4, filtered, and
concentrated in vacuo. The crude product was distilled under reduced pressure collecting
fractions that distilled above room temperature, yielding 8.13 g (29.9 mmol, 82%) of a
yellow-orange liquid. 1H NMR (400 MHz, CDCl3)  1.47 (s, 18H, Se satellites 3JSe‐H =
5.5 Hz); 77Se NMR (76 MHz, CDCl3)  487.8.
2.7.8 Synthesis of (R)-N-Boc--MeSec(Mob)-OEt (9)

A flame dried, 25 mL round bottom flask fitted with a reflux condenser and a
nitrogen atmosphere was charged with a stir bar, selenium (38 mg, 0.480 mmol), THF (2
mL), and LiEt3BH (500 L, 0.500 mmol) which was heated to solvent reflux for 1 hour.
The reaction was cooled to room temperature and 4a (140 mg, 0.350 mmol) dissolved in
THF (2 mL) was added. The reaction was heated to solvent reflux for an additional 15
hours after which the solution was filtered and concentrated in vacuo. The crude yellow
oil (52 mg) was added to a 5 mL conical vial that was charged with a spin vane and
methanol (2 mL). To this solution was added sodium borohydride (6 mg, 0.160 mmol)
which caused effervescence and turned the solution from yellow to colorless. To this
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solution was then added 4-methoxybenzyl chloride (23 L, 0.170 mmol). The reaction
mixture was stirred at 55 °C for 20 hours. The reaction was cooled to room temperature
and diluted with diethyl ether (2 mL) and washed with water (3 × 2 mL). The aqueous
phases were extracted with diethyl ether (2 × 1 mL). The organic phases were pooled,
dried over MgSO4, filtered, and concentrated in vacuo. The crude residue was dissolved
in 10:1 hexanes/ethyl acetate and loaded onto the Chromatotron and eluted with
hexanes/ethyl acetate (10:1 to 8:1). Product rich fractions (Rf = 0.06 in 10:1
hexanes/ethyl acetate) were pooled and concentrated in vacuo to afford 3.1 mg (.007
mmol, 1.4%). 1H NMR (400 MHz, CDCl3)  7.21 (d, 3JH-H = 8.6 Hz, 2H), 6.82 (d, 3JH-H
= 8.7 Hz, 2H), 5.51 (br s, 1H), 4.20 (q, 3JH-H = 7.1 Hz, 2H), 3.79 (s, 3H), 3.77 (d, 2JH-H =
11.5 Hz, 1H), 3.74 (d, 2JH-H = 11.5 Hz, 1H), 3.35 (br d, 2JH-H = 11.5 Hz, 1H), 3.11 (d, 2JHH

= 13.1 Hz, 1H), 1.44 (s, 3H), 1.26 (t, 3JH-H = 7.2 Hz, 3H); LRMS (ESI+) Calcd for

C19H25NO5Se [M + Na]+ 454.11 found 454.15.
2.7.9 Synthesis of tert-butyl Chloromethyl Selenide (10)

A flame dried, 250 mL, 3-necked round bottom flask with a nitrogen atmosphere
was charged with a stir bar, 6 (7.52 g, 27.6 mmol), and dry DCM (75 mL 1.2 mol). The
reaction mixture was cooled with an ice bath and Red-Al (18 mL, 55.4 mmol) was added
dropwise until the solution turned colorless and turbid and effervescence ceased. The
reaction mixture was stirred for an additional 30 minutes and the solution was diluted
with diethyl ether (150 mL) and washed with a chilled 10% Rochelle salt solution (3 ×
100 mL). The organic phase was dried over MgSO4 and filtered, and the solvent was
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removed in vacuo to afford 46.2 mmol (84%, determined by NMR) of a colorless oil,
which was carried on directly to the following reaction. 1H NMR (400 MHz, CDCl3) 
4.87 (s, 2H), 1.55 (s, 9H, Se satellites 3JSe‐H = 5.6 Hz); 77Se NMR (76 MHz, CDCl3) 
518.8.
2.7.10 Synthesis of Diethyl ((tert-butylselanyl)methyl)methylmalonate (12)

A flame dried, 250 mL, 3-necked round bottom flask with a nitrogen atmosphere
was charged with a stir bar, sodium hydride (60% dispersion in mineral oil) (1.53 g, 38.3
mmol), and THF (25 mL). To this suspension was added diethyl methylmalonate (5.30
mL, 31.1 mmol) in THF (25 mL) producing effervescence and heat. This solution was
stirred at room temperature for one hour. Another flame dried 100 mL round bottom flask
with a nitrogen atmosphere was charged with a stir bar, 6 (4.37 g, 16.1 mmol) in THF (10
mL), and LiEt3BH (35 mL, 35 mmol). This solution was then cannulated to a flame dried,
100 mL round bottom flask containing a stir bar and DCM (10.0 mL, 156 mmol) and was
left to react for 30 minutes at room temperature. The solvent was removed in vacuo and
the residue was cannulated into the round bottom flask containing the enolate anion. A
reflux condenser was fitted to the round bottom flask and the reaction mixture was
brought to solvent reflux for 16.5 hours. The reaction mixture was cooled to room
temperature and stirred for an additional 5 hours. The reaction mixture was diluted with
diethyl ether (50 mL) and washed with water (4 × 50 mL). The aqueous phase was
extracted with diethyl ether (2 × 20 mL). All organic phases were pooled, dried over
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MgSO4, filtered, and concentrated in vacuo. The crude liquid was purified by gradient
flash chromatography and eluted with hexanes/ethyl acetate (12:1 to 10:1 to 6:1). The
product rich fractions (Rf = 0.57 in 4:1 hexanes/ethyl acetate) were pooled and
concentrated in vacuo to afford 2.65 g (8.20 mmol, 26%) of a colorless liquid. IR (Neat,
cm−1) 2978, 2939, 2893, 1729; 1H NMR (400 MHz, CDCl3)  4.19 (q, 3JH-H = 7.1 Hz,
4H), 3.05 (s, 2H), 1.49 (s, 3H), 1.43 (s, 9H, Se satellites 3JSe‐H = 5.4 Hz), 1.26 (t, 3JH-H =
7.1 Hz, 6H); 13C NMR (100 MHz, CDCl3)  171.3, 61.5, 54.4 (Se satellites 2JSe‐C = 4.6
Hz), 39.1 (Se satellites 1JSe‐C = 29.8 Hz), 32.2 (Se satellites 2JSe‐C = 6.6 Hz), 26.8 (Se
satellites 1JSe‐C = 36.9 Hz), 21.0, 14.0; 77Se NMR (76 MHz, CDCl3)  340.3; LRMS
(ESI+) Calcd for C13H24O4Se [M + Na]+ 347.07 found 347.17.
2.7.11 Synthesis of 2-((tert-butylselanyl)methyl)-3-ethoxy-2-methyl-3-oxopropanoic
acid (13)

2.7.11.1 Enzymatic Hydrolysis (a)
A 50 mL beaker was charged with a stir bar, 12 (91 mg, 0.280 mmol), 7.6 pH
phosphate buffer (20 mL), and crude porcine liver esterase (2 mg, 18 units/mg). The
reaction was stirred vigorously with a constant pH = 7.4 by titrating 1M NaOH into the
reaction. The reaction was complete after stirring for 17 hours. The solution pH was
raised to 9 with the addition of 1M NaOH and was washed with DCM (20 mL). The
aqueous phase was reacidified to pH = 3 with 1M HCl and extracted with diethyl ether
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(20 mL). The organic phase was dried over MgSO4, filtered, and concentrated in vacuo to
afford 40 mg (0.135 mmol, 49%) of a slightly brown tinged oil. IR (Neat, cm−1) 2972,
2957, 2938, 2892, 1709; 1H NMR (400 MHz, CDCl3)  6.80 (br s, 1H), 4.23 (q, 3JH-H =
7.1 Hz, 2H), 3.10 (d, 2JH‐H = 11.6 Hz, 1H), 3.04 (d, 2JH‐H = 11.6 Hz, 1H), 1.55 (s,
3H),1.44 (s, 9H, Se satellites 3JSe‐H = 5.5 Hz), 1.30 (t, 3JH-H = 7.0, 3H); 13C NMR (100
MHz, CDCl3)  177.0, 171.2, 62.0, 54.5, 39.5, 32.2 (Se satellites 2JSe-C = 6.6 Hz), 26.6,
21.1, 14.0; 77Se NMR (76 MHz, CDCl3)  343.9; LRMS (ESI+) Calcd for C11H20O4Se
[M - tBu]+ 238.98 found 238.92; []D23 = −0.8° (c = 4.4, CHCl3).
2.7.11.2 Racemic Hydrolysis (b)
A 50 mL round bottom flask was charged with a stir bar, 12 (514 mg, 1.59 mmol),
THF (10 mL), lithium hydroxide (44 mg, 1.9 mmol), and water (10 mL). The reaction
mixture was stirred at room temperature for 19 hours and 1M HCl was added to lower the
pH to 3. The solution was diluted with diethyl ether (10 mL) and washed with 0.1M HCl
(3 × 10 mL). The aqueous phases were extracted with diethyl ether (10 mL). The organic
phases were pooled, dried over MgSO4, filtered, and concentrated in vacuo to afford 385
mg (1.30 mmol, 82%) of a colorless liquid. 1H NMR (400 MHz, CDCl3)  9.98 (br s,
1H), 4.23 (q, 3JH-H = 7.1 Hz, 2H), 3.10 (d, 2JH‐H = 11.6 Hz, 1H), 3.04 (d, 2JH‐H = 11.6 Hz,
1H), 1.55 (s, 3H),1.44 (s, 9H, Se satellites 3JSe‐H = 5.5 Hz), 1.30 (t, 3JH-H = 7.0, 3H); 77Se
NMR (76 MHz, CDCl3)  342.9
2.7.12 Synthesis of Dimethyl ((tert-butylselanyl)methyl)methylmalonate (14)
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A flame dried, 250 mL, 3-necked round bottom flask with a nitrogen atmosphere
was charged with a stir bar and sodium hydride (60% dispersion in mineral oil) (1.61 g,
40.3 mmol). The sodium hydride was washed with two portions of pentane. A suspension
was created with the addition of THF (60 mL). The suspension was cooled with an ice
bath and dimethyl methylmalonate (4.84 g, 33.1 mmol) was added dropwise, which
produced effervescence. The reaction mixture was stirred at room temperature for 90
minutes and 10 (46.1 mmol) was added. The reaction mixture was stirring at room
temperature for 2 hours and then heated to solvent reflux for 60 hours. The reaction
mixture was cooled to room temperature, filtered through a bed of Celite, and
concentrated in vacuo. The residue was reconstituted with diethyl ether (100 mL) and
washed with water (5 × 100 mL). The organic phase was dried over MgSO4, filtered, and
concentrated in vacuo. The crude oil was purified by gradient flash chromatography and
eluted with hexanes/ethyl acetate (8:1 to 4:1). The product rich fractions (Rf = 0.50 in 4:1
hexanes/ethyl acetate) were pooled and concentrated in vacuo to afford 7.81 g (26.5
mmol, 80%) of a colorless oil. IR (CDCl3, cm−1) 2953, 2891, 2861, 1731; 1H NMR (400
MHz, CDCl3)  3.74 (s, 6H), 3.05 (s, 2H), 1.51 (s, 3H), 1.43 (s, 9H, Se satellites 3JSe‐H =
5.5 Hz); 13C NMR (100 MHz, CDCl3)  171.7, 54.5 (Se satellites 2JSe‐C = 4.8 Hz), 52.7,
39.3 (Se satellites 1JSe‐C = 29.0 Hz), 32.2 (Se satellites 2JSe‐C = 6.6 Hz), 26.8 (Se satellites
1

JSe‐C = 37.0 Hz), 21.0; 77Se NMR (76 MHz, CDCl3)  342.6; HRMS (ESI+) Calcd for

C11H20O4Se [M + Na]+ 319.0419 found 319.0420.
2.7.13 Synthesis of 2-((tert-butylselanyl)methyl)-3-methoxy-2-methyl-3oxopropanoic acid (15)
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2.7.13.1 Enzymatic Hydrolysis (a)
A 100 mL beaker was charged with a stir bar, 14 (3.24 g, 11.0 mmol), 7.6 pH
phosphate buffer (40 mL), and crude porcine liver esterase (52 mg, 18 units/mg). The
reaction was stirred vigorously with a constant pH = 7.4 by titrating 1M NaOH into the
reaction. The reaction was complete after stirring for 4 hours. The solution pH was raised
to 9 with the addition of 1M NaOH and was washed with diethyl ether (60 mL). The
aqueous phase was reacidified to pH = 3 with 4M HCl and extracted with DCM (3 × 60
mL). The organic phase was filtered through a bed of Celite, dried over MgSO4, and
concentrated in vacuo to afford 3.03 g (10.8 mmol, 98%, ee = 88%) of a slightly brown
tinged oil. IR (CDCl3, cm−1) 2955, 2889, 1709, 1636; 1H NMR (400 MHz, CDCl3)  9.26
(br s, 1H), 3.77 (s, 3H), 3.09 (d, 2JH‐H = 11.6 Hz, 1H), 3.04 (d, 2JH‐H = 11.6 Hz, 1H), 1.54
(s, 3H),1.43 (s, 9H, Se satellites 3JSe‐H = 5.5 Hz); 13C NMR (100 MHz, CDCl3)  177.2,
171.5, 54.5 (Se satellites 2JSe‐C = 5.1 Hz), 52.9, 39.6 (Se satellites 1JSe‐C = 29.3 Hz), 32.2
(Se satellites 2JSe‐C = 6.6 Hz), 26.5 (Se satellites 1JSe‐C = 37.8 Hz), 21.1; 77Se NMR (76
MHz, CDCl3)  344.5; HRMS (ESI+) Calcd for C10H18O4Se [M + Na]+ 305.0263 found
305.0267; []D23 = −2.1° (c = 1.07, CHCl3).
2.7.13.2 Racemic Hydrolysis (b)
A 25 mL round bottom flask was charged with a stir bar, 14 (514 mg, 1.74 mmol),
THF (5 mL), lithium hydroxide (47 mg, 1.9 mmol), and water (5 mL). The reaction
mixture was stirred at room temperature for 30 hours, and 1M NaOH was added to raise
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the pH to 9. The solution was diluted with water (6 mL) and washed with DCM (2 × 6
mL). The aqueous phase was reacidified with 1M HCl to pH = 3 and then extracted with
diethyl ether (9 mL). The organic phase was dried over MgSO4, filtered, and concentrated
in vacuo to afford 450 mg (1.60 mmol, 92%) of a colorless liquid. 1H NMR (400 MHz,
CDCl3)  5.99 (br s, 1H), 3.76 (s, 3H), 3.09 (d, 2JH‐H = 11.6 Hz, 1H), 3.04 (d, 2JH‐H = 11.6
Hz, 1H), 1.53 (s, 3H),1.43 (s, 9H, Se satellites 3JSe‐H = 5.5 Hz).
2.7.14 Synthesis of (R)-N-Fmoc--MeSec(tBu)-OMe (16)

A 25 mL round bottom flask with a nitrogen atmosphere was charged with a stir
bar, 15 (578 mg, 2.06 mmol), dichloroethane (DCE) (5 mL), and TEA (0.35 mL, 2.5
mmol). The reaction mixture was stirred for 5 minutes and DPPA (0.50 mL, 2.3 mmol)
was added. A reflux condenser was fitted to the round bottom flask and the reaction
mixture was stirred for 5 hours at room temperature and heated to solvent reflux for 19
hours. The reaction mixture was cooled to room temperature, diluted with DCE (10 mL),
washed with chilled saturated NH4Cl (15 mL), dried over MgSO4, filtered, and
concentrated in vacuo to afford a yellow tinged turbid oil. The oil was reconstituted in
benzene (5 mL) and added to a 25 mL round bottom flask with a stir bar. To the solution
was added 9‐fluorenemethanol (416 mg, 2.12 mmol) and titanium (IV) tert‐butoxide
(0.10 mL, 0.260 mmol). The reaction mixture was stirred at room temperature for 29
hours and then diluted with diethyl ether (15 mL). This solution was washed with
saturated NH4Cl (4 × 15 mL). The aqueous phases were extracted with DCM (25 mL).
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All organic phases were pooled, dried over MgSO4, filtered, and concentrated in vacuo to
afford a crude yellow oil. The crude product was purified by flash chromatography and
eluted with 2:3 diethyl ether/hexanes. The product rich fractions (Rf = 0.36 in 2:3 diethyl
ether/hexanes) were pooled and concentrated in vacuo to afford 626 mg (1.32 mmol,
64%) of a colorless oil. IR (CDCl3, cm−1) 3415, 3349, 2952, 2890, 1721, 1500, 1478,
1449; 1H NMR (400 MHz, CDCl3)  7.75 (d, J = 7.5 Hz, 2H), 7.61 (d, J = 7.5 Hz, 2H),
7.39 (t, J = 7.4 Hz, 2H), 7.31 (td, J = 7.4, 1.1 Hz, 2H), 5.85 (br s, 1H), 4.29 (m, 3H), 3.78
(s, 3H), 3.48 (br d, 2JH‐H = 11.2 Hz, 1H), 3.09 (br d, 2JH‐H = 11.1 Hz, 1H), 1.69 (s, 3H),
1.41 (s, 9H); 13C NMR (100 MHz, CDCl3)  173.6, 154.6, 143.9, 141.3, 127.7, 127.1,
125.2, 120.0, 66.8, 60.1, 53.0, 47.2, 39.4, 32.3 (Se satellites 2JSe‐C = 6.6 Hz), 28.7, 24.1;
Se NMR (76 MHz, CDCl3)  334.9; HRMS (ESI+) Calcd for C24H29NO4Se [M + Na]+
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498.1154 found 498.1161; []D23 = +8.9° (c = 1.01, CHCl3).
2.7.15 Synthesis of (R)-N-Fmoc--MeSec(tBu)-OH (20)

A 50 mL round bottom flask fitted with a reflux condenser was charged with a stir
bar, 16 (1.29 g, 2.73 mmol), 1,4‐dioxane (10 mL), and 5M HCl (10 mL). The reaction
mixture was heated to solvent reflux for 50 hours. The reaction mixture was cooled to
room temperature and extracted with DCM (3 × 10 mL). The organic phases were
concentrated in vacuo, and the resulting viscous yellow residue was reconstituted with
diethyl ether (30 mL). The solution was washed with 0.1M HCl (5 × 20 mL). The organic
phase was dried over MgSO4, filtered, and concentrated in vacuo. Residual solvent was
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removed by azeotropic drying with pentane to afford 1.15 g (2.50 mmol, 92%) of a
yellow tinged viscous oil. IR (CDCl3, cm−1) 3404, 2955, 1707, 1502, 1450; 1H NMR (400
MHz, CDCl3)  7.75 (d, J = 7.8 Hz, 2H), 7.60 (d, J = 7.4 Hz, 2H), 7.39 (t, J = 7.4 Hz,
2H), 7.31 (td, J = 7.4, 0.8 Hz, 2H), 5.77 (br s, 1H), 4.28 (m, 3H), 3.39 (d, J = 11.1 Hz,
1H), 3.18 (d, J = 10.9 Hz, 1H), 1.71 (s, 3H), 1.41 (s, 9H); 13C NMR (100 MHz, CDCl3) 
177.7, 154.9, 143.8, 141.3, 127.7, 127.1, 125.2, 120.0, 67.0, 59.7, 47.1, 39.6, 32.3 (Se
satellites 2JSe‐C = 6.6 Hz), 28.7, 24.1; 77Se NMR (76 MHz, CDCl3)  331.0; HRMS (ESI+)
Calcd for C23H27NO4Se [M + Na]+ 484.0998 found 484.1001; []D23 = +2.6° (c = 1.01,
CHCl3).
2.7.16 Synthesis of (S)-1-tert-butyl 3-methyl 2-((tert-butylselanyl)methyl)-2methylmalonate (21)

A 50 mL round bottom flask was charged with a stir bar, DCM (13 mL), MgSO4
(1.77 g, 14.8 mmol), and concentrated sulfuric acid (0.20 mL, 3.7 mmol). Clumped
MgSO4 was broken up by vigorously stirring. To this suspension was added a solution of
15a (1.03 g, 3.67 mmol) in DCM (7 mL). Tert‐butanol (1.75 mL, 18.3 mmol) was added
dropwise, and the flask was tightly sealed and stirred for 47 hours. The reaction mixture
was filtered washed with saturated NaHCO3 (20 mL) and brine (20 mL). The organic
phase was dried over MgSO4, filtered, and concentrated in vacuo to afford 807 mg (2.39
mmol, 65%) of an amber‐tinged liquid. IR (CDCl3, cm−1) 2975, 2952, 1728; 1H NMR
(400 MHz, CDCl3)  3.73 (s, 3H), 3.03 (d, 2JH‐H = 11.4 Hz, 1H), 3.00 (d, 2JH‐H = 11.4 Hz,
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1H), 1.46 (s, 3H), 1.45 (s, 9H), 1.43 (s, 9H, Se satellites 3JSe‐H 5.3 Hz); 13C NMR (100
MHz, CDCl3)  172.2, 170.3, 82.0, 55.0 (Se satellites 2JSe‐C = 4.8 Hz), 52.4, 39.0 (Se
satellites 1JSe‐C = 29.3 Hz), 32.2 (Se satellites 2JSe‐C = 6.6 Hz), 27.8, 26.8 (Se satellites
1

JSe‐C = 37.0 Hz), 20.8; 77Se NMR (76 MHz, CDCl3)  339.3; HRMS (ESI+) Calcd for

C14H26O4Se [M + Na]+ 361.0889 found 361.0893; []D23 = −9.6° (c = 1.00, CHCl3).
2.7.17 Synthesis of (S)-3-(tert-butoxy)-2-((tert-butylselanyl)methyl)-2-methyl-3oxopropanoic acid (22)

A 25 mL round bottom flask was charged with a stir bar, 21 (498 mg, 1.48 mmol),
THF (6.0 mL), lithium hydroxide (117 mg, 4.9 mmol), and water (6.0 mL). The reaction
mixture was stirring at room temperature for 16 hours. The pH was reduced to 3 using
4M HCl, diluted with diethyl ether (15 mL), and washed with saturated NH4Cl (3 × 15
mL). The organic phase was then dried over MgSO4, filtered, and concentrated in vacuo
to afford 437 mg (1.35 mmol, 92%) of a yellow tinged oil. IR (CDCl3, cm−1) 2977, 1707;
1

H NMR (400 MHz, CDCl3)  10.69 (br s, 1H), 3.06 (d, 2JH‐H = 11.4 Hz, 1H), 3.00 (d,

2

JH‐H = 11.4 Hz, 1H), 1.50 (s, 3H), 1.47 (s, 9H), 1.44 (s, 9H, Se satellites 3JSe‐H 5.6 Hz);
C NMR (100 MHz, CDCl3)  177.3, 170.4, 82.7, 54.9 (Se satellites 2JSe‐C = 4.8 Hz),

13

39.2 (Se satellites 1JSe‐C = 29.0 Hz), 32.2 (Se satellites 2JSe‐C = 6.6 Hz), 27.8, 26.7 (Se
satellites 1JSe‐C = 37.0 Hz), 21.1; 77Se NMR (76 MHz, CDCl3)  342.3; HRMS (ESI+)
Calcd for C13H24O4Se [M + Na]+ 347.0732 found 347.0734; []D23 = −2.4° (c = 1.00,
CHCl3).
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2.7.18 Synthesis of (S)-N-Fmoc--MeSec(tBu)-OtBu (23)

A 25 mL round bottom flask with a nitrogen atmosphere was charged with a stir
bar, 22 (888 mg, 2.75 mmol), DCE (10 mL), and TEA (0.50 mL, 3.6 mmol). The reaction
mixture was stirring for 5 minutes and DPPA (650 L, 3.0 mmol) was added. The round
bottom flask was fitted with a reflux condenser and the reaction mixture was stirred for
an additional hour and then heated to solvent reflux for 17 hours. The reaction mixture
was cooled to room temperature, diluted with DCE (10 mL), and washed with chilled
saturated NH4Cl (20 mL). The organic phase was dried over MgSO4, filtered, and
concentrated in vacuo to afford a turbid oil. The oil was reconstituted in a 25 mL round
bottom flask using benzene (10 mL). This flask was charged with a stir bar, 9‐
fluorenemethanol (545 mg, 2.78 mmol), and titanium (IV) tert‐butoxide (0.10 mL, 0.260
mmol). The reaction mixture was stirred at room temperature for 47 hours. Saturated
NH4Cl (10 mL) was added, and the reaction mixture was stirred for 3.5 hours. The
reaction mixture was diluted with diethyl ether (20 mL), washed with saturated NH4Cl (2
× 20 mL), and water (20 mL). The emulsion was extracted with diethyl ether (20 mL).
The organic phases were pooled, dried over MgSO4, filtered, and concentrated in vacuo
to afford a crude oil. This oil was purified by gradient flash chromatography and eluted
with hexanes/diethyl ether (8:1 to 4:1). The product rich fractions (Rf = 0.57 in 2:3
diethyl ether/hexanes) were pooled and concentrated in vacuo to afford 786 mg (1.52
mmol, 55%) of a colorless, gummy solid. IR (CDCl3,cm−1) 3413, 2973, 1715; 1H NMR
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(400 MHz, CDCl3)  7.76 (d, J = 8.0 Hz, 2H), 7.62 (dd, J = 7.4, 2.9 Hz, 2H), 7.39 (t, J =
7.4 Hz, 2H), 7.31 (td, J = 7.4, 1.1 Hz, 2H), 5.96 (s, 1H), 4.28 (m, 3H), 3.51 (d, 2J = 11.2
Hz, 1H), 3.05 (d, 2J = 11.2 Hz, 1H), 1.69 (s, 3H), 1.50 (s, 9H), 1.41 (s, 9H); 13C NMR
(100 MHz, CDCl3)  172.2, 154.5, 144.1, 143.9, 141.3, 127.6, 127.0, 125.3, 119.9, 82.7,
66.7, 60.2 (Se satellites 2JSe‐C = 4.0 Hz), 47.2, 39.0, 32.4 (Se satellites 2JSe‐C = 6.6 Hz),
28.4, 27.9, 24.2; 77Se NMR (76 MHz, CDCl3)  336.8; HRMS (ESI+) Calcd
forC27H35NO4Se [M + Na]+ 540.1624 found 540.1626; []D23 = +7.7° (c = 1.00, CHCl3).
2.7.19 Synthesis of (S)-N-Fmoc--MeSec(tBu)-OH (24)

A 25 mL round bottom flask was charged with a stir bar, 23 (546 mg, 1.06 mmol),
DCM (10 mL), and trifluoroacetic acid (10.0 mL, 14.9 mmol). The reaction mixture was
stirred for 2 hours at room temperature and the solvent was removed in vacuo. The
residue was reconstituted in diethyl ether (10 mL) and washed with saturated NH4Cl (3 ×
10 mL). The organic phase was dried over MgSO4, filtered, and concentrated in vacuo.
Residual solvent was removed by azeotropic drying with pentane to afford 487 mg (1.06
mmol, quantitative) of a gummy, foamy solid. IR (CDCl3,cm−1) 3400, 3065, 2955, 1707,
1503, 1450; 1H NMR (400 MHz, CDCl3)  8.99 (br s, 1H), 7.76 (d, J = 7.5 Hz, 2H), 7.60
(d, J = 7.4 Hz, 2H), 7.39 (d, J = 7.4 Hz, 2H), 7.31 (td, J = 7.4, 0.8 Hz, 2H), 5.77 (br s,
1H), 4.29 (m, 3H), 3.36 (d, J = 10.5 Hz, 1H), 3.18 (d, J = 10.6 Hz, 1H), 1.70 (s, 3H), 1.41
(s, 9H); 13C NMR (100 MHz, CDCl3)  178.0, 155.1, 143.7, 141.3, 127.7, 127.1, 125.1,
120.0, 67.2, 59.7, 39.8, 32.3 (Se satellites 2JSe‐C = 6.2 Hz), 28.6, 24.0; 77Se NMR (76
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MHz, CDCl3)  330.2; HRMS (ESI+) Calcd for C23H27NO4Se [M + Na]+ 484.0998 found
484.1000; []D23 = −2.7° (c = 1.07, CHCl3).
2.7.20 Synthesis of (R)-methyl 2-((tert-butylselanyl)methyl)-4-diazo-2-methyl-3oxobutanoate (25)

A flame dried, 50 mL round bottom flask was charged with a stir bar, 15a (506
mg, 1.80 mmol), DCM (10 mL), and oxalyl chloride (500 L, 5.83 mmol). To this
solution was then added DMF (1 drop) causing effervescence. The reaction mixture was
stirred for 14 hours at room temperature and the volatiles were removed in vacuo. The
residue was reconstituted in diethyl ether (10 mL) and cooled to -10 °C. To this solution
was added 0.1715 M ethereal solution of diazomethane (52 mL, 8.9 mmol) was added.
The reaction mixture placed in a freezer set at -10 °C for 15 hours. The reaction mixture
was warmed to room temperature and bubbled with N2. The solvent was removed in
vacuo to afford 529 mg (1.73 mmol, 96%) of a yellow oil. IR (CDCl3,cm−1) 3099, 2953,
2107, 1732, 1633; 1H NMR (400 MHz, CDCl3)  5.49 (s, 1H), 3.74 (s, 3H), 3.08 (d, 2JH-H
= 11.4 Hz, 1H, Se satellites 2JSe‐H 3.1 Hz), 2.98 (d, 2JH-H = 11.5 Hz, 1H, Se satellites 2JSe‐H
3.0 Hz), 1.48 (s, 3H), 1.43 (s, 9H, Se satellites 3JSe‐H 5.5 Hz); 13C NMR (100 MHz,
CDCl3)  191.8, 172.4, 58.3 (Se satellites 2JSe-C = 4.4 Hz), 54.0, 52.8, 39.5 (Se satellites
1

JSe-C = 29.0 Hz), 32.2 (Se satellites 2JSe‐C = 6.6 Hz), 27.0 (Se satellites 1JSe-C = 37.0 Hz),

20.8; 77Se NMR (76 MHz, CDCl3)  343.5; HRMS (ESI+) Calcd for C11H18N2O3Se [M +
Na]+ 329.0375 found 329.0378.
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2.7.21 Synthesis of (R)-3-((tert-butylselanyl)methyl)-4-methoxy-3-methyl-4oxobutanoic acid (26)

A 50 mL round bottom flask was charged with a stir bar, 25 (1.07 g, 3.50 mmol),
THF (14 mL), and water (6 mL). The reaction mixture was sparged with N2 for 15
minutes. The reaction mixture was placed 11.5 cm away from a UV lamp and exposed to
UV radiation for 42 hours at room temperature with positive N2 pressure. The volatiles
were removed in vacuo and the residues pH was brought to 9 with 1M NaOH. The
solution was washed with diethyl ether (20 mL). The aqueous phase was acidified with
4M HCl to pH = 3 which caused red precipitate to form. The solution was extracted with
diethyl ether (40 mL). The organic phase was dried over MgSO4, filtered, and
concentrated in vacuo to afford 662 mg (2.24 mmol, 64%) of a yellow liquid. IR
(CDCl3,cm−1) 2953, 2891, 1729, 1708; 1H NMR (400 MHz, CDCl3)  10.12 (br s, 1H),
3.71 (s, 3H), 2.94 (d, 2JH-H = 11.5 Hz, 1H), 2.92 (d, 2JH-H = 16.8 Hz, 1H), 2.91 (d, 2JH-H =
11.5 Hz, 1H), 2.69 (d, J = 16.7 Hz, 1H), 1.42 (s, 9H, Se satellites 3JSe-H = 5.0 Hz), 1.36 (s,
3H); 13C NMR (100 MHz, CDCl3)  177.1, 175.5, 52.3, 44.5 (Se satellites 2JSe-C = 4.0
Hz), 41.8, 39.3 (Se satellites 1JSe-C = 29.0 Hz), 32.3 (Se satellites 2JSe‐C = 6.2 Hz), 30.1
(Se satellites 1JSe-C = 37.4 Hz), 23.3; 77Se NMR (76 MHz, CDCl3)  328.6; HRMS (ESI+)
Calcd for C11H20O4Se [M + Na]+ 319.0419 found 319.0424; []D25 = 4.1° (c = 1.01,
CHCl3).
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2.7.22 Synthesis of (R)-methyl 3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2((tert-butylselanyl)methyl)-2-methylpropanoate (27)

A 25 mL round bottom flask was charged with a stir bar, 26 (359 mg, 1.21 mmol),
DCE (5 mL), and TEA (210 L, 1.51 mmol). The reaction mixture was stirring for 5
minutes and DPPA (290 L, 1.35 mmol) was added. The round bottom flask was fitted
with a reflux condenser and the reaction mixture was stirred for an additional 1.5 hours
and then heated to solvent reflux for 28 hours. The reaction mixture was cooled to room
temperature, diluted with DCE (10 mL), and washed with chilled saturated NH4Cl (15
mL). The organic phase was dried over MgSO4, filtered, and concentrated in vacuo to
afford a turbid oil. The oil was reconstituted in a 50 mL round bottom flask using
benzene (10 mL). This flask was charged with a stir bar, 9‐fluorenemethanol (246 mg,
1.25 mmol), and titanium (IV) tert‐butoxide (50 L, 0.129 mmol). The reaction mixture
was stirred at room temperature for 4 days. Saturated NH4Cl (10 mL) was added, and the
reaction mixture was stirred for 30 minutes. The reaction mixture was diluted with
diethyl ether (20 mL), washed with saturated NH4Cl (3 × 20 mL). The organic phase was
pooled, dried over MgSO4, filtered, and concentrated in vacuo to afford a crude oil. This
oil was purified by gradient flash chromatography and eluted with 2:3 diethyl
ether/hexanes. The product rich fractions (Rf = 0.27 in 2:3 diethyl ether/hexanes) were
pooled and concentrated in vacuo to afford 142 mg (0.291 mmol, 24%) of a colorless,
gummy solid. IR (Et2O,cm−1) 3363, 3064, 2971, 2950, 2889, 1716, 1611, 1600; 1H NMR
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(400 MHz, CDCl3)  7.75 (d, JH-H = 7.0 Hz, 2H), 7.59 (d, JH-H = 7.4 Hz, 2H), 7.38 (t, JH-H
= 7.4 Hz, 2H), 7.30 (t, JH-H = 7.4 Hz, 2H), 5.30 (br t, JH-H = 6.3 Hz, 1H), 4.30 (m, 3H),
3.71 (s, 3H), 3.47 (dd, JH-H = 14.0, 6.1 Hz, 1H) 3.41 (dd, JH-H = 13.9, 7.3 Hz, 1H), 2.79 (s,
2H), 1.41 (s, 9H, Se satellites 3JSe-H = 5.4 Hz), 1.29 (s, 3H); 13C NMR (100 MHz, CDCl3)
 175.7, 156.7, 144.0, 141.3, 127.7, 127.1, 125.1, 120.0, 66.9, 52.2, 47.9, 47.7, 47.3, 39.2
(Se satellites 1JSe-C = 29.0 Hz), 32.2 (Se satellites 2JSe‐C = 6.6 Hz), 28.2 (Se satellites 1JSe-C
= 37.4 Hz), 21.7; 77Se NMR (76 MHz, CDCl3)  336.4; HRMS (ESI+) Calcd for
C25H31NO4Se [M + Na]+ 512.1311 found 512.1305; []D24 = 3.4° (c = 0.88, CHCl3).
2.7.23 Synthesis of (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-((tertbutylselanyl)methyl)-2-methylpropanoic acid (28)

A 10 mL round bottom flask fitted with a reflux condenser was charged with a stir
bar, 27 (90 g, 0.180 mmol), 1,4‐dioxane (3 mL), and 5M HCl (3 mL). The reaction
mixture was heated to solvent reflux for 48 hours. The reaction mixture was cooled to
room temperature and extracted with diethyl ether (20 mL) and washed with 0.1M HCl (5
× 20 mL). The organic phase was dried over MgSO4, filtered, and concentrated in vacuo.
Residual solvent was removed by azeotropic drying with pentane to afford 29 mg (0.062
mmol, 34%) of a yellow tinged viscous oil. IR (CDCl3, cm−1) ; 1H NMR (400 MHz,
CDCl3)  9.81 (br s), 7.74 (d, J = 7.0 Hz, 2H), 7.58 (d, J = 7.3 Hz, 2H), 7.37 (t, J = 7.1
Hz, 2H), 7.29 (t, J = 7.2 Hz, 2H), 5.38 (br t, JH-H = 5.9 Hz, 1H), 4.34 (m, 3H), 3.34 (m,
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2H), 2.81 (s, 2H), 1.41 (s, 9H), 1.32 (s, 3H); 77Se NMR (76 MHz, CDCl3)  334.2;
HRMS (ESI+) Calcd for C24H29NO4Se [M + Na]+ 498.1154 found 498.1149.
2.7.24 Synthesis of (S)-tert-butyl 2-((tert-butylselanyl)methyl)-4-diazo-2-methyl-3oxobutanoate (29)

A flame dried, 50 mL round bottom flask was charged with a stir bar, 22 (430 mg,
1.24 mmol), DCM (10 mL), and oxalyl chloride (500 L, 5.83 mmol). To this solution
was then added DMF (1 drop) which caused effervescence. The reaction mixture was
stirred for 16 hours at room temperature and the volatiles were removed in vacuo. The
residue was reconstituted in diethyl ether (10 mL) and cooled to -10 °C. To this solution
was added 0.2206 M ethereal solution of diazomethane (51 mL, 11 mmol) was added.
The reaction mixture placed in a freezer set at -10 °C for 16 hours. The reaction mixture
was warmed to room temperature and bubbled with N2. The solvent was removed in
vacuo to afford 276 mg (0.794 mmol, 64%) of a yellow oil. IR (CDCl3,cm−1) 2977, 2937,
2893, 2112, 1722, 1635; 1H NMR (400 MHz, CDCl3)  5.46 (s, 1H), 3.08 (d, 2JH-H = 11.2
Hz, 1H), 2.90 (d, 2JH-H = 11.4 Hz, 1H), 1.47 (s, 9H), 1.43 (s, 12H); 13C NMR (100 MHz,
CDCl3)  192.5, 170.8, 82.3, 58.7, 53.5, 39.0, 32.2, 27.7, 27.0, 20.7; 77Se NMR (76 MHz,
CDCl3)  340.5.
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CHAPTER III – DIRECT DETERMINATION OF ABSOLUTE STEREOCHEMISTRY
OF -METHYLSELENOCYSTEINE USING THE MOSHER METHOD

3.1 Background
Enzymatic hydrolysis utilizing pig liver esterase (PLE) can be a reliable method
to form chiral carboxylic acids. Based on literature precedence, PLE prefers to create the
(R)-enantiomer, however there are substrates known to cause PLE to produce the (S)enantiomer.60-62, 84 Because there is uncertainty with the configuration of the resulting
stereocenter with untested substrates, empirical methods are needed to ascertain the
absolute configuration of the newly generated stereocenter.
One method for determining absolute configuration is polarimetry. Polarimetry is
a nondestructive method that passes plane polarized monochromatic light through a
solution containing a chiral compound. As the plane polarized light passes through the
sample, the plane is rotated the from the normal, with enantiomers rotating the plane in
directions opposed to each other. One drawback to this method is to determine absolute
stereochemistry, specific rotations need to be compared to appropriate analogues with
known configurations because direction of rotation does not establish (R)- or (S)stereochemistry. While having the same designation, (R)-serine and (R)-cysteine rotate
plane polarized light in opposite directions. This method, while excellent at determining
optical purity, lacks a means to independently and unambiguously determine absolute
configuration.
Another method to determine absolute configuration is x-ray crystallography. Xray crystallography functions by hitting a high purity crystal with a beam of x-rays and
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measuring the diffraction pattern produced. From this diffraction pattern and
computational analysis, a very accurate 3-dimensional molecular structure can be
determined. One of the problems that prevents this method from being utilized routinely
is the process of creating a single crystal large and pure enough for analysis. Many
organic materials are liquids under standard conditions, and some materials, if able to
become solid under standard conditions, only form as amorphous solids and are unable to
be analyzed by this technique. While this method can produce a precise 3-dimensional
representation of a molecule, its utility is limited to crystalline solids. Crystalline
materials can also be problematic, as twinning or cracking can form in the crystal
preventing easy structure elucidation with the crystallography technique.
Another method of determining the absolute configuration of a stereocenter is
through synthetic means, such as kinetic resolutions. Enantiomers will react at different
rates, producing enantio-enriched products, if chiral catalysts or chiral reagents are
used.87-89 Modelling the intermediate complex in models such as the Zimmerman-Traxler
model, one enantiomer will form a more stabilized intermediate from spatial and
electrostatic interactions, which can be used to explain the difference in reaction kinetics
between the enantiomers.90 The differences in kinetic rates, combined with the modelling
the intermediate complex, can be used to determine the stereochemistry of the starting
material. While kinetic resolution is a powerful tool to determine absolute configuration,
the substrate may be incompatible with the asymmetric reactions needed for the process;
the functional group needed in the reaction may be absent in the substrate, or other
functional groups present could be sensitive to the required reaction conditions, affecting
the reaction kinetics in unpredictably.
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The Mosher method is another method to determine absolute configuration and
has seen numerous uses as a reliable method to analyze stereocenters and chirality of
organic molecules by utilizing NMR spectroscopy,91-93 which is especially useful when
X-ray crystallography cannot be used. It can not only establish %ee, but also the absolute
stereochemistry of an ambiguous stereocenter when applied correctly. This method relies
on the principle of magnetic anisotropy, or a nonuniform magnetic environment.94 This
magnetic inequivalence is caused by local magnetic fields created by the valence and
bonding electrons that resist the external magnetic field produced by the spectrometer,
which has the effect of shielding the nucleus giving it a slightly different frequency. This
effect is felt by nuclei by through-bond interactions and can be influenced by induction
effects caused by dipoles, or electron delocalization from bond resonance. Magnetic
anisotropy can also occur from through-space interactions which occurs through electrons
in -systems. The movement of these -electrons creates large, conical shaped, shielding
environments, with the ability to shield any NMR active nuclei that sit spatially inside of
them (Figure 3.1).
Magnetic anisotropy from spatial interactions was recognized very early on in the
development of practical NMR in the mid 1960’s with the differences in diastereomers
and enantiomers in chiral solvents well established,95 but it wasn’t until Mosher’s article
in 1973, where his method was initially developed, that the physics of the spatial
interactions of these systems directly correlated absolute stereochemistry to chemical
shifts.91 Before that time, anisotropic effects were used by many, as it is still used today,
to determine optical purity.96-99
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Figure 3.1 Magnetic Anisotropy in -Systems and Shielding Effects from These Systems

Mosher synthesized esters (or amides) using enantiopure carboxylic acids or acyl
chlorides of known configurations at the -carbon, containing an aromatic group, which
were coupled with secondary alcohols (amines). When modeling these esters (amides)
with a specific conformation, he found an upfield shift from groups that were on the same
side of the MTPA-plane as, or ipsilateral to, the MTPA-phenyl group (Figure 3.2). While
it may not be the lowest energy conformer, this conformation is thought be significant on
the NMR timescale.93, 100 Early in this work, three aromatic containing carboxylic acids
were used, mandelic acid, O-methylmandelic acid, and -methoxy-trifluoromethylphenylacetic acid (MTPA), however Mosher found that MTPA gave more
straightforward and consistent results than the other two molecules since mandelates and
O-methylmandelates have the potential to epimerize.96-97
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Figure 3.2 Anisotropic Trends Seen with MTPA with Required Conformation

MTPA also allows for the option to use 19F NMR to be used for analysis as well which
allows for additional confirmation of optical purity determination or stereocenter
assignment, however for stereocenter assignment it may be difficult to utilize.101-102
For the Mosher method to produce predictable results, an alcohol or amine is
needed to be on a chiral, secondary carbon. If this carbon is tertiary, the formed ester or
amide will not sit in the MTPA-plane as proposed by Mosher due to the steric congestion
around this carbon, and will instead have a different conformation than what is expected
for accurate assignment; instead without a hydrogen present on the carbinyl carbon
(carbon attached to the heteroatom) to sit in the MTPA-plane, the molecule would be
expected to adopt one of the available staggered conformations (Figure 3.3). When the
carbon is tertiary, many opt to use the Mosher method to determine enantio-purity and
use other empirical methods instead to determine absolute stereochemistry. To date, there
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is only one source that has utilized the Mosher method to determine the configuration of
a tertiary carbon, but the authors used computational analysis to approximate what to
expect for the non-ideal conformation to aid in the interpretation of the spectra to identify
the stereochemistry.103

Figure 3.3 Steric Interactions from a Tertiary Carbinyl Carbon

Currently, there seems to be a gap in knowledge using the Mosher method to
analyze amides with a tertiary carbinyl carbon. With the correct substrates, amides should
accurately predict unknown configurations over their ester counterparts, especially if a
group around the carbinyl carbon has the capability to hydrogen bond with the amide
hydrogen atom (Figure 3.4). Mosher found that when either mandelic or atrolactic acids
were used to make the diastereomeric esters and amides, the  were greater than that of
the MTPA analogues.91, 97
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Figure 3.4 Rigidity of Conformers Caused by Hydrogen Bonding

He postulated that large  was caused by the mandelates having the ability to hydrogen
bond to the carbonyl allowing for more rigidity of the acid moiety of the ester.91 With the
substrate having the ability to hydrogen bond with the amide hydrogen, it should be
possible to accurately assign the absolute configuration of the -carbon of an -MeAA
with the Mosher method.

3.2 Synthesis and Analysis of the Mosher Amides
With the potential for hydrogen bonding between the amide hydrogen and the
ester carbonyl, it is hypothesized that the conformation of the parent amino ester will sit
in a predictable orientation that will allow for the determination of its unknown
stereocenter (Figure 3.5).

Figure 3.5 Hypothesized Amino Ester Conformations in the MPTA-Plane
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The Mosher method was used to accurately assign the configuration of the MeSec analogue that was previously synthesized 20, which was hypothesized to be of
(R)-configuration based on comparisons to the optical rotation of its -MeCys
counterpart104 of known stereochemistry. Amino ester 31 was converted to two
diastereomeric MTPA amides, (X,R)-32 and (X,S)-32, where X is the unassigned
stereocenter on the carbinyl carbon, through a series of reactions with known retention of
stereochemistry (Scheme 3.1). Several spectra were obtained for each diastereomer and
were compared to observe any magnetic anisotropy present.

Scheme 3.1 Synthesis of the MTPA-Amides

In the 1H spectra, the -methyl hydrogen atoms show strong shielding effects
from the MTPA-phenyl group (+13.4 Hz using the (X,S) - (X,R) convention) which
correlates to the -methyl group of the carbinyl carbon being ipsilateral to the MTPAphenyl group in (X,R)-32 and not in (X,S)-32 (Figure 3.6). Due to the diastereotopic
nature of the methylene protons adjacent to the selenium ( +1.7 and  +11.6 Hz),
these protons did not shift as expected. The unexpected shift could be caused by other
effects, such as the electronic environment imposed by the selenium atom, interfering
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with the anisotropy caused by the MTPA-phenyl.91 The tert-butyl group protons ( -6.2
Hz), experienced a small anisotropic effect believed to be caused by the large distance
from the MTPA-phenyl group. With the data presented in the 1H spectra, the side groups
take the configurations that presented in Figure 3.6 for each diastereomer.

Figure 3.6 1H NMR Spectra of the sp3 regions of (X,S)-32 and (X,R)-32

More agreeable evidence for stereocenter assignment is gained from 13C NMR,
especially from the carbons adjacent to the carbinyl carbon. In agreement with 1H
spectra, the -methyl carbon ( +28.6 Hz) experienced a large anisotropic shift, with
the -methyl carbon ipsilateral to the MTPA-phenyl group in (X,R)-32 (Figure 3.7). The
methylene carbon ( -43.5 Hz) also experienced a large anisotropic effect that
corroborates the previous configurational assignment (Figure 3.6). The quaternary tertbutyl carbon ( -14.8 Hz) also experienced a shift in the same direction of the
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methylene carbon, but much more diminished, due to an increased distance from the
MTPA-phenyl group.

Figure 3.7 13C NMR Spectra of the sp3 regions of (X,S)-32 and (X,R)-32

The methyl carbons of the tert-butyl group did not experience any measurable shift
difference, which is caused by the increased distance from the MTPA-phenyl group
tapering the effect of the anisotropy that the phenyl group confers. With all the 13C
resonances analyzed, the configuration of the side groups can be more confidently
assigned (Figure 3.7), which agrees with the assignment proposed from the 1H spectra.
Useful configurational information can be gained from the 19F NMR spectra as
well. The signals from the trifluoromethyl groups of the MTPA are magnetically
inequivalent (Figure 3.8) with (X,S)-32 experiencing an upfield anisotropic shift when
compared to (X,R)-32. Based on past literature precedence,91, 100-102 this can be caused by
steric interactions between a bulky side group and the MTPA-phenyl group causing a
destabilization of the preferred conformation, forcing trifluoromethyl group to sit outside
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the preferred deshielding cone of the MTPA-carbonyl longer than average. This
destabilization results in fluorine atoms ultimately showing an upfield shift in the
spectrum.

Figure 3.8 19F NMR Spectra of the Trifluoromethyl Groups Showing Steric Interactions

Bearing in mind the size of the side groups, there is a direct relationship with whether the
phenyl group and the tert-butyl selenide group share the same side of the MTPA-plane
and the chemical shift of the trifluoromethyl group (Figure 3.8).
Since selenium has a wide chemical shift range for the selenide functionality, and
high sensitivity to the electronic environment,7, 82, 105 it was hypothesized that 77Se NMR
could give large anisotropic shifts assignment of the configuration of the unknown
stereocenter. The selenium shifts observed (Figure 3.9) opposed the configuration that
the 1H, 13C, and 19F spectra predicted. An effect that could have influenced the
anisotropic shift the selenium experiences is the large electron cloud around selenium.
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Figure 3.9 77Se Spectra of (X,S)-32 and (X,R)-32 Spiked with Diphenyl Diselenide

This large electron cloud shields the nucleus from the magnetic field and prevents the
expected anisotropic effects from the MTPA-phenyl group.82
Based on all the spectra collected, there is strong supporting evidence that the side
groups sit in the positions proposed in Figures 3.6-3.8 leaving the ester to sit in the
MTPA-plane. With the ester carbonyl sitting anti to the amide hydrogen, there will be
repulsive electrostatic forces exerted between the ester and amide carbonyls (Figure
3.10a). The inverse is true if the ester carbonyl sits syn to the amide hydrogen, since a
stabilization occurs from the amide hydrogen atom hydrogen bonding to ester carbonyl
(Figure 3.10b). This would be very similar to what Mosher et al. observed when working
with mandelates.91 With the ester in the expected syn-orientation, the absolute
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configuration of the -carbon of 20 is (R). This assignment confirms the expected
configuration when comparing the optical rotation of 20 ([]D23 = 2.6° (c = 1.01, CHCl3))
to its -MeCys analogue ([]D24 = 2.0° (c = 1.0 CH2Cl2)).104

Figure 3.10 The Anti and Syn Arrangements of the Ester of Each Amide

After the Mosher analysis was complete, it was discovered that x-ray quality
crystals were able to be grown from the enzymatic hydrolysis product 15a. While 15a
was not used directly in the Mosher study, it was used in the synthesis of 20 using
reactions that retain stereochemistry. The crystal was formed by dissolving 15a in a
minimal amount of n-octane and allowing for slow evaporation of the solvent. Single
crystal x-ray diffraction was performed by Dr. Douglas Powell at the University of
Oklahoma. The data confirmed an (R)-stereochemistry of the -carbon, validating the
results of the independent Mosher analysis (Figure 3.11). The crystallography was
completed with ellipsoid displacement probability of 50%.
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Figure 3.11 X-Ray Crystal Structure of 15a

Based on these results, the Mosher method can be used to determine the absolute
configuration of a quaternary -carbon of an enantiopure -MeAA. To confirm the
conclusions from the NMR spectral analysis, X-ray crystallography was performed on a
synthetically related structure which validated the procedure. Even with the parent
molecule sitting in an unconventional orientation in the MTPA-plane for the Mosher
method, the magnetic anisotropy is still able to be used to correctly interpret the unknown
stereochemistry by analyzing standard NMR nuclei. While only implemented on MeSec, the Mosher method could be extended to other -MeAA’s to determine
ambiguous stereocenter configurations especially if crystallography is unable to be
performed.
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3.3 Experimental
3.3.1 General Procedures
All NMR spectra were obtained using a Bruker 400 MHz spectrometer in CDCl3
or CD3CN. Chemical shifts for 1H and 13C spectra are referenced from TMS ( 0.00 ppm)
with TMS as an internal standard. Chemical shifts for 77Se spectra are referenced with
diphenyl diselenide ( 463 ppm) as an internal standard. All heteronuclear NMR
experiments were 1H decoupled. IR spectra were obtained from a Nicolet Nexus 470 FTIR spectrometer with a Smart Orbit Thermo™ diamond plate ATR attachment as a
solution in CDCl3. Reverse phase HPLC was performed using a C18 (250 x 10 mm)
Vydac column eluting with MeCN:H2O (0-100% over 20 min.).
X-ray data was collected by Dr. Powell and obtained from a colorless, needleshaped crystal of dimensions 0.018 x 0.018 x 0.204 mm. Intensity data for this compound
were collected using a D8 Quest -geometry diffractometer with a Bruker Photon II
CMOS area detector and an Incoatec Is microfocus Mo K source ( = 0.71073 Å). The
sample was cooled to 100 K. Cell parameters were determined from a least-squares fit of
4170 peaks in the range 2.41 <  < 23.51°. A total of 33580 data were measured in the
range 2.406 <  < 26.388° using  and  oscillation frames. The data were corrected for
absorption by the empirical method106 giving minimum and maximum transmission
factors of 0.6704 and 0.7454. The data were merged to form a set of 5315 independent
data with R(int) = 0.1288 and a coverage of 99.9 %.
The orthorhombic space group P212121 was determined by systematic absences
and statistical tests and verified by subsequent refinement. The structure was solved by
direct methods and refined by full-matrix least-squares methods on F2.107-108 The
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positions of hydrogens bonded to carbons were initially determined by geometry and
were refined using a riding model. Hydrogens bonded to oxygens were located on a
difference map, and their positions were refined independently with a restraint on the OH distance. Non-hydrogen atoms were refined with anisotropic displacement parameters.
Hydrogen atom displacement parameters were set to 1.2 (1.5 for methyl) times the
isotropic equivalent displacement parameters of the bonded atoms. A total of 277
parameters were refined against 1 restraint and 5315 data to give wR(F2) = 0.1110 and S
= 1.008 for weights of w = 1/[2 (F2) + (0.0460 P)2], where P = [Fo2 + 2Fc2] / 3. The final
R(F) was 0.0521 for the 3830 observed, [F > 4(F)], data. The largest shift/s.u. was
0.001 in the final refinement cycle. The final difference map had maxima and minima of
0.468 and -0.619 e/Å3, respectively. The absolute structure was determined by
refinement of the Flack parameter.109

3.3.2 Synthesis of (R)-N-Fmoc--MeSec(tBu)-OMe (16)

A 25 mL round bottom flask fitted with a reflux condenser was charged with a stir
bar, 20 (295.0 mg, 0.640 mmol), methanol (10 mL), and concentrated sulfuric acid (20.0
µL, 0.360 mmol). The reaction mixture was heated to solvent reflux for 43 hours and the
volatiles were removed in vacuo. The residue was reconstituted in diethyl ether (5 mL)
and washed with water (3 x 3 mL). The organic phase was dried over magnesium sulfate,
filtered, and concentrated in vacuo to afford 276.6 mg (0.582 mmol, 91%) of 16 as a
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colorless oil. Spectra were identical to what was previously synthesized (See pages 5051).
3.3.3 Synthesis of (R)--MeSec(tBu)-OMe HCl (31)

A 25 mL round bottom flask containing was charged with a stir bar, 16 (314.2
mg, 0.662 mmol), and a 20% piperidine in DMF solution (10 mL). After stirring for 30
min. at room temperature the reaction was diluted with diethyl ether (20 mL) and
extracted with 0.25 M HCl (3 x 20 mL). The aqueous phase was filtered and concentrated
in vacuo to afford 191.1 mg (0.662 mmol, quant.) of 31 as a white solid. 1H NMR (400
MHz, CDCl3)  3.83 (s, 3H), 3.19 (d, 2JH-H = 12.8 Hz, 1H,), 3.09 (d, 2JH-H = 12.8 Hz, 1H),
1.74 (s, 3H), 1.45 (s, 9H, Se satellites 3JSe-H 5.9 Hz); 13C NMR (100 MHz, CD3CN) 
171.0, 61.0, 53.8, 41.6, 31.9, 27.8, 22.6; 77Se NMR (76 MHz, CD3CN)  327.1; HRMS
(ESI+) Calcd for C9H20NO2Se+ 254.0654 found 254.0652.
3.3.4 Synthesis of the Mosher acid chloride

The synthesis was carried out on a 100-150 mg scale with the appropriate MTPA
enantiomer based on previously reported literature procedures.110 The reactions afforded
a yellow oil (74-79%) that were pure enough to carry forward without distillation based
on literature spectra.
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3.3.5 General synthetic procedure N-MTPA--MeSec(tBu)-OMe ((X,R)-32 and
(X,S)-32)
A 25 mL round bottom flask was charged with a stir bar, the appropriate Mosher
acid chloride (75-150 mg), 25 (1.1-1.2 molar equivalence), DCM (3 mL), and TEA (2
molar equivalence). After stirring for 23 hrs. at room temperature the reaction was diluted
with diethyl ether (5 mL) and filtered. The filtrate was concentrated in vacuo to afford a
crude yellow-orange solid. The solid was dissolved in acetonitrile (5 mL) and purified by
reverse phase HPLC (Rt = 17.1 min.) resulting in pure 26 (quantitative) as a colorless oil.
3.3.5.1 (X,S)-32

IR (CDCl3, cm-1) 3383, 2954, 1740, 1698, 1505, 1449; 1H NMR (400 MHz,
CDCl3)  7.72 (br s, 1H), 7.60 (m, 2H), 7.40 (m, 3H), 3.78 (s, 3H), 3.50 (d, 2JH-H = 11.5
Hz, 1H), 3.43 (s, 3H), 3.07 (d, 2JH-H = 11.5 Hz, 1H), 1.71 (s, 3H), 1.40 (s, 9H, Se
satellites 3JSe-H 5.4 Hz); 13C NMR (100 MHz, CDCl3)  173.1, 165.6, 132.2, 129.4, 128.4
128.2, 127.7, 123.8 (q, 1JC-F = 290.0 Hz), 84.1 (q, 2JC-F = 26.2 Hz), 60.2, 55.1, 53.0, 39.6,
32.3 (Se satellites 2JSe-C = 6.6 Hz), 28.1, 23.4; 19F NMR (376 MHz, CDCl3)  -69.1; 77Se
NMR (76 MHz, CDCl3)  331.1; HRMS (ESI+) Calcd for C19H26F3NO4Se [M + H]+
470.1052 found 470.1055.
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3.3.5.2 (X,R)-32

IR (CDCl3, cm-1) 3383, 2954, 1740, 1698, 1505, 1448; 1H NMR (400 MHz,
CDCl3)  7.61 (br s, 1H), 7.58 (m, 2H), 7.39 (m, 3H), 3.75 (s, 3H), 3.51 (s, 3H), 3.50 (d,
2

JH-H = 11.5 Hz, 1H), 3.04 (d, 2JH-H = 11.6 Hz, 1H), 1.67 (s, 3H), 1.41 (s, 9H, Se satellites

2

JSe-H 5.5 Hz); 13C NMR (100 MHz, CDCl3)  173.0, 165.6, 132.7, 129.4, 128.4, 128.2,

127.7, 123.7 (q, 1JC-F = 290.0 Hz), 83.9 (q, 2JC-F = 26.2 Hz), 60.0 (Se satellites 2JSe-C = 4.0
Hz), 55.3, 52.9, 39.7 (Se satellites 1JSe-C = 28.6 Hz), 32.3 (Se satellites 2JSe-C = 6.6 Hz),
28.6 (Se satellites 1JSe-C = 37.4 Hz), 23.1; 19F NMR (376 MHz, CDCl3)  -68.7; 77Se
NMR (76 MHz, CDCl3)  330.1; HRMS (ESI+) Calcd for C19H26F3NO4Se [M + Na]+
492.0864 found 492.0871.
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3.3.6 Crystal Data

Figure 3.12 Unit cell of 15a
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Table 3.1 Crystal Data and Structure Refinement for 15a

Empirical formula

C10 H18 O4 Se

Formula weight
Crystal system
Space group

281.20
orthorhombic
P212121
a = 5.7779(3) Å
= 90°
b = 14.2158(9) Å
= 90°
c = 31.605(3) Å
= 90°
3
2596.0(3) Å
8, 2
1.439 g/mL
0.71073 Å
100(2) K
1152
2.886 mm-1
Semi-empirical from
equivalents
0.7454 and 0.6704
2.406 to 26.388°

Unit cell dimensions

Volume
Z, Z'
Density (calculated)
Wavelength
Temperature
F(000)
Absorption coefficient
Absorption correction
Max. and min. transmission
Theta range for data
collection
Reflections collected
Independent reflections
Data / restraints /
parameters
wR(F2 all data)
R(F obsd data)
Goodness-of-fit on F2
Observed data [I > 2(I)]
Absolute structure
parameter
Largest and mean shift / s.u.
Largest diff. peak and hole

33580
5315 [R(int) = 0.1288]
5315 / 1 / 277
wR2 = 0.1110
R1 = 0.0521
1.008
3830
0.003(10)
0.001 and 0.000
0.468 and -0.619 e/Å3
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Table 3.2 Atomic coordinates and equivalent isotropic displacement parameters for 15a.

U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.

x
Se(1A) 0.09631(14)
O(1A) 0.5841(9)
O(2A) 0.2526(9)
O(3A) 0.5068(10)
O(4A) 0.5460(9)
C(1A) 0.2904(14)
C(2A) 0.4615(14)
C(3A) 0.4168(16)
C(4A) 0.1139(16)
C(5A) 0.3274(11)
C(6A) 0.3054(12)
C(7A) 0.0627(12)
C(8A) 0.3726(13)
C(9A) 0.6735(13)
C(10A) 0.4668(12)
Se(1B) 1.10849(16)
O(1B) 0.7181(9)
O(2B) 1.0845(10)
O(3B) 0.7974(9)
O(4B) 0.7559(11)
C(1B)
0.8856(16)
C(2B)
0.7610(16)
C(3B)
0.7106(15)
C(4B)
1.0382(14)
C(5B)
0.9098(14)
C(6B)
0.9781(13)
C(7B)
1.2309(12)
C(8B)
0.9430(13)
C(9B)
0.6548(15)
C(10B) 0.8292(12)

y
0.40465(6)
0.5642(3)
0.6393(4)
0.3822(4)
0.5374(4)
0.3749(5)
0.4529(6)
0.2817(5)
0.3667(6)
0.3949(5)
0.4778(5)
0.4851(5)
0.5706(5)
0.6506(6)
0.4625(5)
0.32673(7)
0.5208(4)
0.5721(4)
0.5120(4)
0.3555(4)
0.2771(5)
0.1911(6)
0.3528(6)
0.2509(6)
0.3370(6)
0.4232(6)
0.4184(6)
0.5135(6)
0.6076(7)
0.4318(6)
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z
0.52499(3)
0.48619(16)
0.4703(2)
0.39683(18)
0.39408(18)
0.5751(3)
0.5836(3)
0.5690(3)
0.6113(3)
0.4798(2)
0.4483(3)
0.4291(3)
0.4694(2)
0.5040(3)
0.4111(3)
0.19572(3)
0.23474(18)
0.23841(17)
0.32698(19)
0.3279(2)
0.1532(2)
0.1710(3)
0.1415(3)
0.1160(3)
0.2456(2)
0.2718(3)
0.2867(3)
0.2464(3)
0.2147(3)
0.3114(3)

U(eq)
0.0226(2)
0.0210(13)
0.0263(14)
0.0257(14)
0.0227(15)
0.0212(19)
0.029(2)
0.029(2)
0.033(2)
0.0158(17)
0.0166(18)
0.0207(19)
0.0189(17)
0.029(2)
0.0164(18)
0.0342(3)
0.0280(15)
0.0288(14)
0.0270(14)
0.0307(16)
0.0234(18)
0.035(2)
0.037(2)
0.031(2)
0.0255(19)
0.023(2)
0.027(2)
0.024(2)
0.041(3)
0.0193(19)

Table 3.3 Bond Lengths [Å] 15a

Bond
Se(1A)-C(5A)
Se(1A)-C(1A)
O(1A)-C(8A)
O(1A)-C(9A)
O(2A)-C(8A)
O(3A)-C(10A)
O(4A)-C(10A)
O(4A)-H(4A)
C(1A)-C(2A)
C(1A)-C(3A)
C(1A)-C(4A)
C(2A)-H(2A1)
C(2A)-H(2A2)
C(2A)-H(2A3)
C(3A)-H(3A1)
C(3A)-H(3A2)
C(3A)-H(3A3)
C(4A)-H(4A1)
C(4A)-H(4A2)
C(4A)-H(4A3)
C(5A)-C(6A)
C(5A)-H(5A1)
C(5A)-H(5A2)
C(6A)-C(10A)
C(6A)-C(8A)
C(6A)-C(7A)
C(7A)-H(7A1)
C(7A)-H(7A2)
C(7A)-H(7A3)
C(9A)-H(9A1)
C(9A)-H(9A2)
C(9A)-H(9A3)

Length
1.960(7)
1.985(8)
1.335(9)
1.447(9)
1.198(8)
1.250(9)
1.278(9)
0.75(6)
1.511(11)
1.524(10)
1.538(11)
0.98
0.98
0.98
0.98
0.98
0.98
0.98
0.98
0.98
1.547(10)
0.99
0.99
1.515(10)
1.528(10)
1.531(10)
0.98
0.98
0.98
0.98
0.98
0.98
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Bond
Se(1B)-C(5B)
Se(1B)-C(1B)
O(1B)-C(8B)
O(1B)-C(9B)
O(2B)-C(8B)
O(3B)-C(10B)
O(4B)-C(10B)
O(4B)-H(4B)
C(1B)-C(4B)
C(1B)-C(3B)
C(1B)-C(2B)
C(2B)-H(2B1)
C(2B)-H(2B2)
C(2B)-H(2B3)
C(3B)-H(3B1)
C(3B)-H(3B2)
C(3B)-H(3B3)
C(4B)-H(4B1)
C(4B)-H(4B2)
C(4B)-H(4B3)
C(5B)-C(6B)
C(5B)-H(5B1)
C(5B)-H(5B2)
C(6B)-C(10B)
C(6B)-C(8B)
C(6B)-C(7B)
C(7B)-H(7B1)
C(7B)-H(7B2)
C(7B)-H(7B3)
C(9B)-H(9B1)
C(9B)-H(9B2)
C(9B)-H(9B3)

Length
1.956(8)
1.991(8)
1.355(9)
1.434(10)
1.195(9)
1.256(9)
1.275(10)
0.75(6)
1.515(11)
1.522(11)
1.526(11)
0.98
0.98
0.98
0.98
0.98
0.98
0.98
0.98
0.98
1.531(11)
0.99
0.99
1.524(11)
1.529(12)
1.536(10)
0.98
0.98
0.98
0.98
0.98
0.98

Table 3.4 Bond Angles [°] for 15a

Bonds
C(5A)-Se(1A)-C(1A)
C(8A)-O(1A)-C(9A)
C(10A)-O(4A)-H(4A)
C(2A)-C(1A)-C(3A)
C(2A)-C(1A)-C(4A)
C(3A)-C(1A)-C(4A)
C(2A)-C(1A)-Se(1A)
C(3A)-C(1A)-Se(1A)
C(4A)-C(1A)-Se(1A)
C(1A)-C(2A)-H(2A1)
C(1A)-C(2A)-H(2A2)
H(2A1)-C(2A)-H(2A2)
C(1A)-C(2A)-H(2A3)
H(2A1)-C(2A)-H(2A3)
H(2A2)-C(2A)-H(2A3)
C(1A)-C(3A)-H(3A1)
C(1A)-C(3A)-H(3A2)
H(3A1)-C(3A)-H(3A2)
C(1A)-C(3A)-H(3A3)
H(3A1)-C(3A)-H(3A3)
H(3A2)-C(3A)-H(3A3)
C(1A)-C(4A)-H(4A1)
C(1A)-C(4A)-H(4A2)
H(4A1)-C(4A)-H(4A2)
C(1A)-C(4A)-H(4A3)
H(4A1)-C(4A)-H(4A3)
H(4A2)-C(4A)-H(4A3)
C(6A)-C(5A)-Se(1A)
C(6A)-C(5A)-H(5A1)
Se(1A)-C(5A)-H(5A1)
C(6A)-C(5A)-H(5A2)
Se(1A)-C(5A)-H(5A2)
H(5A1)-C(5A)-H(5A2)
C(10A)-C(6A)-C(8A)
C(10A)-C(6A)-C(7A)
C(8A)-C(6A)-C(7A)

Angle
100.5(3)
115.1(6)
110(7)
110.3(7)
110.9(7)
110.2(7)
110.8(6)
110.9(6)
103.6(5)
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
111.1(5)
109.4
109.4
109.4
109.4
108
107.8(6)
105.5(6)
110.3(6)
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Bonds
C(5B)-Se(1B)-C(1B)
C(8B)-O(1B)-C(9B)
C(10B)-O(4B)-H(4B)
C(4B)-C(1B)-C(3B)
C(4B)-C(1B)-C(2B)
C(3B)-C(1B)-C(2B)
C(4B)-C(1B)-Se(1B)
C(3B)-C(1B)-Se(1B)
C(2B)-C(1B)-Se(1B)
C(1B)-C(2B)-H(2B1)
C(1B)-C(2B)-H(2B2)
H(2B1)-C(2B)-H(2B2)
C(1B)-C(2B)-H(2B3)
H(2B1)-C(2B)-H(2B3)
H(2B2)-C(2B)-H(2B3)
C(1B)-C(3B)-H(3B1)
C(1B)-C(3B)-H(3B2)
H(3B1)-C(3B)-H(3B2)
C(1B)-C(3B)-H(3B3)
H(3B1)-C(3B)-H(3B3)
H(3B2)-C(3B)-H(3B3)
C(1B)-C(4B)-H(4B1)
C(1B)-C(4B)-H(4B2)
H(4B1)-C(4B)-H(4B2)
C(1B)-C(4B)-H(4B3)
H(4B1)-C(4B)-H(4B3)
H(4B2)-C(4B)-H(4B3)
C(6B)-C(5B)-Se(1B)
C(6B)-C(5B)-H(5B1)
Se(1B)-C(5B)-H(5B1)
C(6B)-C(5B)-H(5B2)
Se(1B)-C(5B)-H(5B2)
H(5B1)-C(5B)-H(5B2)
C(10B)-C(6B)-C(8B)
C(10B)-C(6B)-C(5B)
C(8B)-C(6B)-C(5B)

Angle
101.0(3)
115.5(7)
111(8)
111.8(7)
111.3(7)
110.0(7)
103.5(6)
110.1(6)
109.9(6)
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
109.5
110.2(5)
109.6
109.6
109.6
109.6
108.1
106.9(7)
111.3(6)
110.7(7)

Table 3.4 (continued)

Bonds
C(10A)-C(6A)-C(5A)
C(8A)-C(6A)-C(5A)
C(7A)-C(6A)-C(5A)
C(6A)-C(7A)-H(7A1)
C(6A)-C(7A)-H(7A2)
H(7A1)-C(7A)-H(7A2)
C(6A)-C(7A)-H(7A3)
H(7A1)-C(7A)-H(7A3)
H(7A2)-C(7A)-H(7A3)
O(2A)-C(8A)-O(1A)
O(2A)-C(8A)-C(6A)
O(1A)-C(8A)-C(6A)
O(1A)-C(9A)-H(9A1)
O(1A)-C(9A)-H(9A2)
H(9A1)-C(9A)-H(9A2)
O(1A)-C(9A)-H(9A3)
H(9A1)-C(9A)-H(9A3)
H(9A2)-C(9A)-H(9A3)
O(3A)-C(10A)-O(4A)
O(3A)-C(10A)-C(6A)
O(4A)-C(10A)-C(6A)

Angle
109.8(6)
110.8(6)
112.4(6)
109.5
109.5
109.5
109.5
109.5
109.5
125.1(7)
124.6(7)
110.3(6)
109.5
109.5
109.5
109.5
109.5
109.5
122.9(7)
121.7(7)
115.3(7)
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Bonds
C(10B)-C(6B)-C(7B)
C(8B)-C(6B)-C(7B)
C(5B)-C(6B)-C(7B)
C(6B)-C(7B)-H(7B1)
C(6B)-C(7B)-H(7B2)
H(7B1)-C(7B)-H(7B2)
C(6B)-C(7B)-H(7B3)
H(7B1)-C(7B)-H(7B3)
H(7B2)-C(7B)-H(7B3)
O(2B)-C(8B)-O(1B)
O(2B)-C(8B)-C(6B)
O(1B)-C(8B)-C(6B)
O(1B)-C(9B)-H(9B1)
O(1B)-C(9B)-H(9B2)
H(9B1)-C(9B)-H(9B2)
O(1B)-C(9B)-H(9B3)
H(9B1)-C(9B)-H(9B3)
H(9B2)-C(9B)-H(9B3)
O(3B)-C(10B)-O(4B)
O(3B)-C(10B)-C(6B)
O(4B)-C(10B)-C(6B)

Angle
106.8(7)
108.9(7)
112.1(7)
109.5
109.5
109.5
109.5
109.5
109.5
123.1(8)
127.3(7)
109.6(7)
109.5
109.5
109.5
109.5
109.5
109.5
124.4(8)
118.5(8)
117.0(7)

Table 3.5 Anisotropic displacement parameters (Å2x 103) for 15a.
The anisotropic displacement factor exponent takes the form: -2 2[ h2 a*2 U11 + ... + 2 h
k a* b* U12]

Se(1A)
O(1A)
O(2A)
O(3A)
O(4A)
C(1A)
C(2A)
C(3A)
C(4A)
C(5A)
C(6A)
C(7A)
C(8A)
C(9A)
C(10A)
Se(1B)
O(1B)
O(2B)
O(3B)
O(4B)
C(1B)
C(2B)
C(3B)
C(4B)
C(5B)
C(6B)
C(7B)
C(8B)
C(9B)
C(10B)

U11
16(1)
16(3)
22(3)
37(3)
28(4)
24(4)
33(5)
35(5)
30(5)
15(3)
15(4)
15(4)
23(4)
28(5)
12(4)
22(1)
21(3)
23(3)
30(3)
36(4)
28(4)
48(6)
31(5)
36(5)
19(4)
21(4)
15(4)
18(5)
32(6)
11(4)

U22
31(1)
19(3)
20(3)
17(3)
21(3)
14(4)
28(5)
27(5)
38(5)
14(4)
17(4)
21(4)
18(4)
26(5)
16(4)
52(1)
40(4)
38(4)
27(4)
31(4)
23(4)
28(5)
33(6)
32(5)
31(5)
27(5)
36(6)
39(5)
60(7)
23(5)

U33
21(1)
29(3)
38(4)
23(3)
20(3)
26(5)
25(5)
24(5)
30(5)
19(4)
17(5)
26(5)
15(4)
32(6)
22(5)
28(1)
24(4)
26(3)
24(4)
26(4)
20(5)
29(6)
46(7)
24(5)
27(5)
21(5)
30(5)
14(5)
32(6)
24(5)
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U23
1(1)
-5(2)
-5(3)
-1(3)
-1(3)
3(4)
-6(4)
2(4)
2(4)
0(4)
3(4)
-5(4)
-1(3)
-12(4)
-1(4)
-18(1)
4(3)
3(3)
-1(3)
-3(3)
-1(4)
7(5)
7(5)
-1(4)
-8(4)
-1(4)
-7(4)
-11(4)
16(5)
-7(4)

U13
U12
3(1)
1(1)
-2(3) -1(3)
-2(3)
1(3)
6(3)
5(2)
8(3)
-2(3)
3(4)
5(4)
-2(4) -4(4)
7(5) 11(5)
18(5) 0(5)
0(3)
1(3)
3(3)
0(3)
-5(4) -1(3)
5(4)
-1(4)
-1(4) -7(4)
-3(3) -3(3)
7(1)
-9(1)
-2(3) -5(3)
2(3)
-4(3)
4(3)
2(3)
12(3) -11(3)
1(4)
-3(4)
-3(5) -19(5)
9(5)
4(4)
2(4)
5(4)
-3(4) -2(4)
5(4)
-7(4)
0(4)
1(4)
3(4)
-2(4)
-5(4) -3(5)
-2(3)
4(3)

Table 3.6 Hydrogen coordinates and isotropic displacement parameters for 15a

H(4A)
H(2A1)
H(2A2)
H(2A3)
H(3A1)
H(3A2)
H(3A3)
H(4A1)
H(4A2)
H(4A3)
H(5A1)
H(5A2)
H(7A1)
H(7A2)
H(7A3)
H(9A1)
H(9A2)
H(9A3)
H(4B)
H(2B1)
H(2B2)
H(2B3)
H(3B1)
H(3B2)
H(3B3)
H(4B1)
H(4B2)
H(4B3)
H(5B1)
H(5B2)
H(7B1)
H(7B2)
H(7B3)
H(9B1)
H(9B2)
H(9B3)

x
y
z
U(eq)
0.600(15) 0.526(6) 0.373(2) 0.03
0.38
0.51
0.59 0.04
0.55
0.44
0.61 0.04
0.57
0.46
0.56 0.04
0.3
0.23
0.56 0.04
0.52
0.29
0.54 0.04
0.5
0.27
0.59 0.04
0
0.32
0.61 0.05
0.2
0.35
0.64 0.05
0.03
0.43
0.61 0.05
0.48
0.39
0.49 0.02
0.31
0.33
0.46 0.02
-0.05
0.5
0.45 0.03
0.06
0.54
0.41 0.03
0.03
0.43
0.41 0.03
0.83
0.64
0.52 0.04
0.68
0.7
0.48 0.04
0.57
0.67
0.53 0.04
0.698(15) 0.365(7) 0.349(2) 0.04
0.66
0.21
0.19 0.05
0.66
0.16
0.15 0.05
0.88
0.14
0.18 0.05
0.62
0.37
0.17 0.06
0.79
0.41
0.13 0.06
0.61
0.33
0.12 0.06
1.15
0.2
0.12 0.05
0.94
0.23
0.09 0.05
1.12
0.31
0.11 0.05
0.75
0.34
0.24 0.03
0.93
0.28
0.26 0.03
1.33
0.41
0.26 0.04
1.27
0.48
0.3 0.04
1.25
0.36
0.31 0.04
0.49
0.61
0.21 0.06
0.68
0.66
0.23 0.06
0.75
0.62
0.19 0.06
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Table 3.7 Torsion angles [°] for 15a

Bonds
Se(1A)-C(5A)-C(6A)-C(10A)
Se(1A)-C(5A)-C(6A)-C(8A)
Se(1A)-C(5A)-C(6A)-C(7A)
C(9A)-O(1A)-C(8A)-O(2A)
C(9A)-O(1A)-C(8A)-C(6A)
C(10A)-C(6A)-C(8A)-O(2A)
C(7A)-C(6A)-C(8A)-O(2A)
C(5A)-C(6A)-C(8A)-O(2A)
C(10A)-C(6A)-C(8A)-O(1A)
C(7A)-C(6A)-C(8A)-O(1A)
C(5A)-C(6A)-C(8A)-O(1A)
C(8A)-C(6A)-C(10A)-O(3A)
C(7A)-C(6A)-C(10A)-O(3A)
C(5A)-C(6A)-C(10A)-O(3A)
C(8A)-C(6A)-C(10A)-O(4A)
C(7A)-C(6A)-C(10A)-O(4A)
C(5A)-C(6A)-C(10A)-O(4A)
Se(1B)-C(5B)-C(6B)-C(10B)
Se(1B)-C(5B)-C(6B)-C(8B)
Se(1B)-C(5B)-C(6B)-C(7B)
C(9B)-O(1B)-C(8B)-O(2B)
C(9B)-O(1B)-C(8B)-C(6B)
C(10B)-C(6B)-C(8B)-O(2B)
C(5B)-C(6B)-C(8B)-O(2B)
C(7B)-C(6B)-C(8B)-O(2B)
C(10B)-C(6B)-C(8B)-O(1B)
C(5B)-C(6B)-C(8B)-O(1B)
C(7B)-C(6B)-C(8B)-O(1B)
C(8B)-C(6B)-C(10B)-O(3B)
C(5B)-C(6B)-C(10B)-O(3B)
C(7B)-C(6B)-C(10B)-O(3B)
C(8B)-C(6B)-C(10B)-O(4B)
C(5B)-C(6B)-C(10B)-O(4B)
C(7B)-C(6B)-C(10B)-O(4B)
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Angle
-173.5(5)
67.5(7)
-56.5(8)
-4.2(11)
175.2(6)
113.9(8)
-0.7(11)
-125.9(8)
-65.4(8)
179.9(6)
54.7(8)
155.8(7)
-86.3(9)
35.0(10)
-28.5(9)
89.4(8)
-149.3(7)
-178.8(5)
62.5(7)
-59.3(8)
-4.6(11)
173.2(7)
115.5(9)
-123.1(9)
0.5(12)
-62.1(8)
59.2(8)
-177.1(7)
-31.8(9)
-152.7(7)
84.7(9)
152.0(7)
31.1(10)
-91.6(9)

Table 3.8 Hydrogen bonds for 15a [Å and °]

D-H...A
O(4A)-H(4A)...O(3B)
O(4B)-H(4B)...O(3A)
C(2B)-H(2B2)...O(4A)#1
C(4B)-H(4B2)...O(2A)#1
C(9B)-H(9B1)...O(2B)#2

d(D-H) d(H...A) d(D...A) <(DHA)
0.75(6) 1.87(6) 2.596(8) 166(10)
0.75(6) 1.90(6) 2.640(8) 171(10)
0.98
2.55
3.485(11)
159
0.98
2.61
3.576(11)
169
0.98
2.58
3.416(10)
143
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CHAPTER IV – SYNTHESIS TOWARDS AN ASYMMETRIC GLUTATHIONE
DISULFIDE

4.1 Background
Glutathione peroxidase (GPx) is a selenoprotein that can reduce hydrogen
peroxide, radical species, and other reactive oxidative species to benign and unreactive
compounds. During the catalytic cycle, the selenium of GPx is oxidized to a selenenic
acid24, 111 and needs to be reduced to become reactivated. The reduction is completed in
two steps using two molar equivalence of the tripeptide glutathione (GSH), with GSH
leaving as the oxidized disulfide, glutathione disulfide (GSSG). As GSSG, it is unable to
perform any other reductions and needs to be reduced to a thiol. The enzyme glutathione
reductase (GR) is responsible for the reduction of GSSG back to GSH.
Glutathione reductase was first discovered in pea cells in 1951,112 was later
discovered in animal tissues in 1952,113 and was isolated from yeast in 1955.114 It has a
very limited substrate scope only known to catalyze the reduction of GSSG; not even
cystine or homocystine can be reduced. These results suggest that the amino acids
adjacent to Cys in GSSG are important in substrate reactivity. Past research has
incorporated -MeCys within GSSG to form an unnatural glutathione disulfide
(G’SSG’), this however acted as a competitive inhibitor of GR.50 Acting as a competitive
inhibitor, G’SSG’ is able to fit in the active site, however the enzyme is unable to act
upon it. Based on computational analysis, this is caused by a deviation in the dihedral
angle, 3, from the normal range of approximately 90° while in the active site. The steric
effects of the -methyl groups present in G’SSG’ causes the dihedral angle to constrict to
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62°, which prevents GR from acting on G’SSG’ (Figure 4.1). To enable normal or
partially inhibited enzymatic function, a 3 dihedral angle closer to the normal value will
be required. It is hypothesized that normal or partial inhibition of GR can be achieved
through the asymmetric glutathione disulfide G’SSG. The reduced steric bulk should
allow for increased mobility around the disulfide bond in G’SSG, allowing for 3 to
approach closer to normal angles in the active site of GR.

Figure 4.1 The 3 Dihedral Angles of GSSG and G’SSG’ as Modelled in GR

Biologically, GSSG is created by the oxidation of two molar equivalences of GSH
to form a symmetric disulfide. Using hydrogen peroxide as the oxidant, GSSG can be
synthesized in an identical manner in a laboratory setting. Previously, G’SH was
synthesized in the Masterson lab utilizing solution phase peptide synthesis, and then
oxidized to G’SSG’ with oxygen.115 This method cannot be used to efficiently create an
asymmetric disulfide, such as G’SSG, otherwise a mixture of products will form, GSSG,
G’SSG, and G’SSG’.
Different synthetic methods are used to create asymmetric disulfides with
peptides and other biomacromolecular structures. Taking advantage of sulfur’s
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nucleophilicity, the thiolate can attack a disulfide bond, substituting one thiolate for
another creating a new disulfide linkage.116 In past literature, the kinetics of the thioldisulfide exchange have been examined, and it was discovered that without catalytic base
the exchange is extremely slow since the thiol is much less nucleophilic than the
thiolate.117 The thiol exchange happens as an SN2 mechanism forming a three membered
intermediate between the sulfurs with the negative charge delocalized between the
exterior sulfurs (Figure 4.2).118

Figure 4.2 General Mechanism for Thiol-Disulfide Exchange

While this method is straightforward, there are issues that can arise when attempting this
chemistry with small molecules. Many of the exchanges are reversible which can cause a
mixture of products. Another problem with the thiol-disulfide exchange method is that
any trace amounts of thiol present with the desired mixed disulfide can cause an
exchange, even at a lower pH since the ionization of a thiol is in equilibrium.118
To overcome the problem of byproducts, many chemists choose to activate one of
the thiols, by either creating a sulfenyl halide,119-120 Bunte salts,121-122 sulfonium salts,123124

or many other electrophilic sulfur species.125-127 Many of these methods, however, rely

on employing harsh reagents, or involve multiple steps with purifications. After the first
thiol is activated and purified, the second thiol is added creating the asymmetric disulfide
(Scheme 4.1).
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Scheme 4.1 Asymmetric Disulfide Synthesis

Hunter et al. developed a method using 1-chlorobenzotriazole (BtCl) in tandem with
benzotriazole (BtH) to activate a thiol, which can then be reacted with the second thiol in
one pot to produce an asymmetric disulfide (Scheme 4.2).128 This method allows for the
direct synthesis of the asymmetric disulfide without intermediary purification steps using
mild reagents.

Scheme 4.2 Hunter’s Approach to Asymmetric Disulfides

4.2 Asymmetric Glutathione Core Synthesis
With the synthesis of N-Boc--MeCys-OMe, it is hypothesized that using the
strategy established by Hunter et al.128 an asymmetric cystine core can be created and
then elaborated to form G’SSG.
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Scheme 4.3 Route to Synthesize the Protected Cysteine Amino Ester

The first step in forming the glutathione core was to first synthesize an
appropriate -MeCys analogue. In most steps the chemistry is analogous to the synthesis
of -MeSec, including an initial alkylation, enzymatic hydrolysis, Curtius rearrangement,
and an alcohol addition (Scheme 4.3).
Synthesis of the thio-alkylated malonate 34 was straightforward and did not suffer
from the synthetic problems that the selenium analogue possessed (Scheme 4.4). The
alkylating agent 33 was directly synthesized from the commercially available tertbutylthiol, with no need for reducing agents that could interfere with later reactions. The
synthesis of 33 was very high yielding and did not require purification.

Scheme 4.4 Synthesis the Half-Ester 35
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The enzymatic hydrolysis of 34 to produce the half-ester 35 was an efficient reaction
obtaining yields comparable to what is in the literature.115
Once 35 was synthesized, a Curtius rearrangement was used to create an
isocyanate intermediate (Scheme 4.5). Following what has been done in the literature, 4methoxybenzyl alcohol was used in the alcohol addition to the isocyanate, producing the
Moz-protected amine 36 in reasonable yields. In addition, tert-butyl alcohol was used
forming the Boc-protected amine 37. The benefit to synthesizing 37 is that purification is
simplified by passing the crude material through silica, eluting with 8:1 hexanes/ethyl
acetate, and collecting eluant until colorless, while the purification of 36 involves
traditional column chromatography, monitoring each fraction for product. The
disadvantage to synthesizing 37 is that a Lewis acid is needed to overcome the steric
effects imposed by tert-butyl alcohol.

Scheme 4.5 Transformation of Half-Ester 35 to Thiol 39
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Both 36 and 37 can be used to in the thiol deprotection step to produce 39, however better
yields are obtained when proceeding from 36. This deprotection is accomplished with
mercury acetate in TFA, creating the mercury adduct 38.129 The adduct is converted into
the desired thiol 39 by bubbling hydrogen sulfide through an aqueous suspension.
Once 39 was synthesized, the amine needed to be reprotected for the asymmetric
disulfide step. Attempting an N-Boc protection with di-tert-butyl dicarbonate (Boc2O)
resulted in low yields of the desired N-Boc protected amine 40 (Scheme 4.6). From NMR
analysis a major unwanted product from this reaction is the S-Boc protected compound
41 (Figure 4.3). From literature precedence, it was possible to selectively deprotect the
sulfur of 41 with sodium hydroxide,130 however this method was only successful in
hydrolyzing the methyl ester.

Scheme 4.6 N-Boc Protection of the Free Amine

96

Figure 4.3 The 1H and 13C NMR Spectra of the Byproduct 41

In attempts to find an efficient route to 40, alternative deprotection methods were
explored. One method explored was utilizing dimethyl(methylthio)sulfonium triflate
(DMTST). Under these conditions, 37 should be converted into a mixed disulfide, which
could then be reduced to form 40 without affecting the N-Boc (Scheme 4.7),131 however
this reaction failed to produce the intermediate mixed disulfide. Another strategy
attempted was Boc protecting the ammonium salt of 38 before the mercury was removed,
but this method was unsuccessful.
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Scheme 4.7 Failed Alternative Routes to 40

With the isolation of 40, the asymmetric G’SSG core could be synthesized
applying the method proposed by Hunter et al.128 Using the method as proposed, 42 was
produced in low yield, with thiourea adducts and cystine contributing to the loss of yield
(Scheme 4.8) which was verified by MS (Figure 4.4).

Scheme 4.8 Formation of the Asymmetric G’SSG core

98

Figure 4.4 Mass Spectrograph of the Crude Product from the Asymmetric Disulfide
Synthesis

Based on the literature, the yield was expected to be higher, however based on the
byproducts formed, the stoichiometry recommended seems incorrect. To ensure complete
conversion to the activated thiol as seen in Scheme 4.2, excess BtCl is used. To quench
the excess BtCl, thiourea is employed, however the paper uses a large excess which is the
probable cause of most of the byproducts.
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4.3 Future Work
With the synthesis of the G’SSG core 42 synthesized, elaboration to form G’SSG
is needed. Using solution phase peptide synthesis, the asymmetric cystine core can be
elaborated to synthesize G’SSG. The first main step in the synthesis would be the
hydrolysis of the methyl ester to allow for the coupling of a glycine analogue (Scheme
4.9). An acid catalyzed ester hydrolysis can potentially cause a Boc deprotection of the
amine, which would ruin the following coupling step, and a base catalyzed ester
hydrolysis could induce disulfide shuffling, causing a mixture of disulfides to form. The
best course of action would be an enzymatic hydrolysis to form 43, which prevents the
potential for side reactions. A glycine alkyl ester can be coupled to the carboxylic acid of
43 to produce the tetrapeptide 44, which the nitrogen can be then be deprotected with
TFA to yield the free amine 45.

Scheme 4.9 The Core-Out Synthesis of G’SSG
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To 45, a backbone protected glutamic acid can be coupled to the free amine to yield 46.
After 46 is formed, a standard acidic hydrolysis can be done to liberate the carboxylic
acid and amines of their protecting groups forming G’SSG. With G’SSG synthesized,
enzymatic testing with GR can be performed to analyze the activity of G’SSG towards
GR.

4.4 Experimental
4.4.1 Materials
Solvents for synthesis from Fisher Scientific (Fair lawn, NJ) or Acros Organics
(Morris Plains, New Jersey). Diphenylphosphoryl azide (DPPA) was purchased from TCI
America (Portland, OR). Titanium (IV) tert-butoxide was purchased from EMD
Millipore. Silica gel (230-400 mesh) for purifications was purchased from Silicycle
(Quebec City, QC, Canada). Deuterated solvents were purchased from Cambridge
Isotope Laboratories (Andover, MA). All other chemicals were purchased from SigmaAldrich (Milwaukee, WI), Fisher Scientific (Waltham, MA), or ACROS Organics
(Pittsburgh, PA). NMR spectra were obtained from a 400 MHz Bruker spectrometer. 1H
and 13C chemical shifts () were reported as downfield from tetramethylsilane and 13C
experiments were 1H decoupled. IR spectra were obtained from a Nicolet Nexus 470 FTIR spectrometer with a Smart Orbit Thermo™ diamond plate ATR attachment and
samples were acquired as neat samples.
4.4.2 Synthesis of tert-butyl(chloromethyl)sulfane (33)
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Compound 33 was prepared according to the reported procedures.84, 115 A 3necked, 500 mL round bottom flask was charged with a stir bar, DCM (175 mL),
paraformaldehyde (6.65 g, 222 mmol), and tert-butylthiol (20.0 mL, 177 mmol). The
reaction mixture was cooled in an ice bath, and with stirring hydrogen chloride was
bubbled through the reaction mixture for 15 minutes. Nitrogen was bubbled through the
reaction mixture for 2 hours to purge excess hydrogen chloride from the system. The
aqueous phase was removed, and the organic phase was dried with MgSO4, filtered, and
concentrated in vacuo to afford 167 mmol (94%) of a yellow tinged liquid. 1H NMR (400
MHz, CDCl3)  4.85 (s, 2H), 1.42 (s, 9H).
4.4.3 Synthesis of dimethyl 2-((tert-butylthio)methyl)-2-methylmalonate (34)

Compound 34 was prepared according to the reported procedures.115, 132 A flame
dried, 500 mL, 3-necked round bottom flask with a nitrogen atmosphere was charged
with a stir bar and sodium hydride (60% dispersion in mineral oil) (6.30 g, 40.3 mmol).
The sodium hydride was washed with two portions of pentane. A suspension was created
with the addition of THF (200 mL). The suspension was cooled with an ice bath and
dimethyl methylmalonate (19.07 g, 130.5 mmol) was added dropwise, which produced
effervescence. The reaction mixture was stirred at room temperature for 2 hours and 33
(157 mmol) was added. The reaction mixture was stirring at room temperature for 1 hour
and then heated to solvent reflux for 17.5 hours. The reaction mixture was cooled to room
temperature, filtered through a bed of Celite, diluted with diethyl ether (150 mL), and
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washed with water (7 × 100 mL). The organic phase was dried over MgSO4, filtered, and
concentrated in vacuo to afford 29.23 g (117.7 mmol, 90%) of a colorless oil. 1H NMR
(400 MHz, CDCl3)  3.74 (s, 6H), 3.03 (s, 2H), 1.50 (s, 3H), 1.31 (s, 9H).
4.4.4 Synthesis of (R)-2-((tert-butylthio)methyl)-3-methoxy-2-methyl-3-oxopropanoic
acid (35)

Compound 35 was prepared according to the reported procedures.115, 132 A 400
mL beaker was charged with a stir bar, 34 (29.30 g, 118.0 mmol), 7.4 pH phosphate
buffer (250 mL), and crude porcine liver esterase (497 mg, 18 units/mg). The reaction
was stirred vigorously with a constant pH = 7.4 by titrating 1M NaOH into the reaction.
The reaction was complete after stirring for 30 hours. The solution pH was raised to 9
with the addition of 1M NaOH and was washed with diethyl ether (300 mL). The
aqueous phase was reacidified to pH = 3 with 4M HCl and extracted with CHCl3 (3 × 400
mL). The organic phase was filtered through a bed of Celite, dried over MgSO4, and
concentrated in vacuo to afford 21.41 g (91.37 mmol, 77%) of a yellow liquid. 1H NMR
(400 MHz, CDCl3)  10.05 (br s, 1H), 3.77 (s, 3H), 3.07 (d, 2JH-H = 12.0 Hz, 1H), 3.02 (d,
2

JH-H = 12.3 Hz, 1H), 1.53 (s, 3H), 1.31 (s, 9H).

4.4.5 Synthesis of (R)-N-Moz--MeCys(tBu)-OMe (36)
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Compound 36 was prepared according to the reported procedures.115, 132 A 250 mL
round bottom flask with a nitrogen atmosphere was charged with a stir bar, 35 (5.01 g, 21.4
mmol), dichloroethane (DCE) (75 mL), and TEA (3.60 mL, 25.8 mmol). The reaction
mixture was stirred for 5 minutes and DPPA (5.10 mL, 23.7 mmol) was added. A reflux
condenser was fitted to the round bottom flask and the reaction mixture was stirred for 1
hour at room temperature and heated to solvent reflux for 16.5 hours. The reaction mixture
was cooled to room temperature, and to the mixture was added 4-methoxybenzyl alcohol
(14.86 g, 107.3 mmol). The reaction mixture was heated to solvent reflux for 24 hours and
the solvent was removed in vacuo. The residue was reconstituted in diethyl ether (100 mL)
and was washed with water (5 × 100 mL). The organic phase was dried over MgSO4,
filtered, and concentrated in vacuo to afford a crude orange oil. The crude product was
purified by flash chromatography and eluted with 2:1 hexanes/ethyl acetate (Rf = 0.61 in
1:1 hexanes/ethyl acetate spiked with 2% TEA). The product rich fractions were pooled
and concentrated in vacuo to afford 6.13 g (16.6 mmol, 78%) of a yellow liquid. 1H NMR
(400 MHz, CDCl3)  7.29 (d, JH-H = 8.9 Hz, 2H), 6.88 (d, JH-H = 8.7 Hz, 2H), 5.72 (br s,
1H), 5.01 (s, 2H), 3.80 (s, 3H), 3.76 (br s, 3H), 3.30 (br d, 2JH-H = 11.9 Hz, 1H), 3.01 (d,
2

JH-H = 12.2 Hz, 1H), 1.63 (br s, 3H), 1.27 (s, 9H).

4.4.6 Synthesis of (R)-N-Boc--MeCys(tBu)-OMe (37)

A 500 mL round bottom flask with a nitrogen atmosphere was charged with a stir
bar, 35 (18.47 g, 78.83 mmol), DCE (150 mL), and TEA (13.2 mL, 94.7 mmol). The
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reaction mixture was stirred for 5 minutes and DPPA (18.0 mL, 83.5 mmol) was added.
A reflux condenser was fitted to the round bottom flask and the reaction mixture was
stirred for 1.5 hours at room temperature and heated to solvent reflux for 20.5 hours. The
reaction mixture was cooled to room temperature, and to the mixture was added tertbutanol (23.5 mg, 247 mmol) and titanium (IV) tert‐butoxide (3.00 mL, 7.77 mmol). The
reaction mixture was heated to solvent reflux for 2.5 days and was washed with saturated
NH4Cl (3 × 150 mL). The organic phase was pooled, dried over MgSO4, filtered, and
concentrated in vacuo to afford a crude brown oil. The crude product was filtered through
silica gel with 8:1 hexanes/ethyl acetate until the eluate became colorless. The eluate was
concentrated in vacuo to afford 17.37 g (56.87 mmol, 72%) of a yellow liquid. IR
(CDCl3, cm−1) 3431, 3370, 2964, 2902, 2866, 1740, 1714; 1H NMR (400 MHz, CDCl3) 
5.43 (br s, 1H), 3.76 (s, 3H), 3.24 (br d, 2JH-H = 11.4 Hz, 1H), 3.05 (d, 2JH-H = 12.2 Hz,
1H), 1.58 (s, 3H), 1.43 (s, 9H), 1.30 (s, 9H); 13C NMR (100 MHz, CDCl3)  173.8, 154.2,
79.6, 59.2, 52.6, 42.2, 34.9, 30.8, 28.3, 23.5.
4.4.7 Synthesis of (R)-H--MeCys-OMe TFA (39)

A 250 mL round bottom flask in an ice bath was charged with a stir bar, TFA
(100 mL), anisole (4.0 mL, 37 mmol), and 36 (6.68 g, 18.1 mmol). To the reaction
mixture was added mercury acetate (5.78 g, 18.2 mmol). After stirring for 30 minutes at 0
°C the volatiles were removed in vacuo. The residue was washed with diethyl ether
several times until a fine grey powder remained. Water (100 mL) was used to create
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suspension a from this powder. A separate 100 mL round bottom flask was charged with
sodium sulfide nonahydrate (19.11 g, 79.57 mmol) and sulfuric acid (4.5 mL, 83 mmol)
which generated hydrogen sulfide. The generated hydrogen sulfide was bubbled through
the suspension creating a black precipitate which was removed by gravity filtration. The
volatiles were removed in vacuo yielding 4.44 g (16.8 mmol, 93%) of a yellow tinged oil.
1

H NMR (400 MHz, CDCl3)  8.62 (br s, 3H), 3.86 (s, 3H), 3.15 (br d, 2JH-H = 14.3 Hz,

1H), 3.04 (br d, 2JH-H = 14.9 Hz, 1H), 1.83 (br s, 1H), 1.70 (s, 3H).

4.4.8 Synthesis of (R)-N-Boc--MeCys-OMe (40)

A 50 mL round bottom flask was charged with a stir bar, 39 (846 mg, 3.21 mmol),
acetonitrile (20 mL), and Boc2O (800 L, 3.48 mmol). To this suspension was added
TEA (450 L, 3.23 mmol). After stirring for 22 hours at room temperature the reaction
mixture was diluted with diethyl ether (40 mL) and washed with water (3 × 40 mL), dried
over MgSO4, filtered, and concentrated in vacuo. The remaining impurities were removed
by distillation under reduced pressure, until no further distillate formed. The pot fraction
yielded 235 mg (0.943 mmol, 29%) of a cream colored solid. 1H NMR (400 MHz,
CDCl3)  5.86 (br s, 1H), 3.78 (s, 3H), 3.66 (br d, 2JH-H = 15.1 Hz, 1H), 3.50 (d, 2JH-H =
14.2 Hz, 1H), 1.60 (s, 3H), 1.53 (s, 1H), 1.46 (s, 9H).
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4.4.9 Synthesis of (R)-methyl 2-((tert-butoxycarbonyl)amino)-3-(((R)-2-((tertbutoxycarbonyl)amino)-3-methoxy-3-oxopropyl)disulfanyl)-2-methylpropanoate
(42)

Compound 42 was prepared according to the reported procedure.128 A 25 mL
round bottom flask was charged with a stir bar, BtCl (215 mg, 1.40 mmol), BtH (85 mg,
0.71 mmol), and DCM (5 mL). The solution was cooled to -63 °C by a liquid
nitrogen/chloroform slurry and a solution of 40 (174 mg, 0.697 mmol) in DCM (1 mL)
was added dropwise. After stirring for 20 minutes at -63 °C, TLC confirmed the absence
of 40 (Rf = 0.61 in 1:1 hexanes/ethyl acetate) and to the reaction mixture was added a
solution of thiourea (152 mg, 2.00 mmol) in THF (2 mL). After stirring for an additional
10 minutes a solution of N-Boc-Cys-OMe (220 L, 1.07 mmol) in DCM (1 mL) was
added dropwise. Slowly warming to room temperature and stirring for 18 hours the
reaction mixture was filtered. The filtrate was concentrated in vacuo and purified by
gradient flash chromatography and eluted with hexanes/ethyl acetate (4:1 to 1:1). The
product rich fractions (Rf = 0.58 in 1:1 hexanes/ethyl acetate) were pooled and
concentrated in vacuo to afford 61 mg (0.126 mmol, 18%) of a colorless gummy solid. 1H
NMR (400 MHz, CDCl3)  5.52 (br s, 1H), 5.41 (br d, J = 7.6 Hz, 1H), 4.61 (m, 1H),
3.77 (s, 3H), 3.76 (s, 3H), 3.56 (br d, J = 13.4 Hz, 1H), 3.36 (d, J = 14.1 Hz, 1H), 3.13 (d,
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J = 5.4 Hz, 2H), 1.57 (s, 3H), 1.45 (s, 9H), 1.44 (s, 9H); 13C NMR (100 MHz, CDCl3) 
173.5, 171.3, 155.1, 154.1, 80.2, 79.8, 59.9, 52.8, 52.6, 45.0, 41.4, 28.3, 28.3, 23.5;
LRMS (ESI+) Calcd for C19H34N2O8S2 [M + Na]+ 505.17 found 505.17.
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APPENDIX A – CHARACTERIZATION DATA FROM SYNTHESES
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